Merops Switch to
Inhibitors

Peptidase

Family Clan SEARCHES BLAST
MEROPS SUBMISSIONS

Other
information

Literature for peptidase S07.001: flavivirin

Summary Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates Pharma

(Topics flags: A Assay, S Structure, T Target, P Specificity, I Inhibitor, E Expression, L Localization, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2025
  1. Bhattacharya,M., Bhowmik,D. and Yin,Q.
    In Vitro Cleavage Assay to Characterize DENV NS2B3 Antagonism of cGAS
    Methods Mol Biol2854, 153-170. PubMed  Europe PubMed DOI
  2. Corliss,L., Petit,C.M. and Lennemann,N.J.
    Subcellular determinants of orthoflavivirus protease activity
    bioRxiv PubMed  Europe PubMed DOI
  3. Kumar,A.
    Differentially labeled flaviviral protease-cofactor complex for NMR spectroscopic applications
    Protein Expr Purif229, 106684-106684. PubMed  Europe PubMed DOI
  4. Murtuja,S., Das,S., Jana,I.D., Shilkar,D., Rakshit,G., Sarkar,B., Sinha,B.N., Dewangan,R.P., Mondal,A. and Jayaprakash,V.
    Identification of novel thiazole derivatives as flaviviral protease inhibitors effective against Dengue (DENV2) and Japanese encephalitis viruses
    Antimicrob Agents Chemothere0165124-e0165124. PubMed  Europe PubMed DOI
  5. Zhu,X., Gao,X., Wu,Y., Lu,J., Chen,X., Zhao,C., Li,H., Zhang,Z., Liu,S., Xiao,G. and Pan,X.
    Eltrombopag, an FDA-approved drug, inhibits dengue virus type 2 by targeting NS2B-NS3 protease
    Virol Sin PubMed  Europe PubMed DOI
    6. 2024
  6. Akram,M., Hameed,S., Hassan,A. and Khan,K.
    Development in the Inhibition of Dengue Proteases as Drug Targets
    Curr Med Chem31, 2195-2233. PubMed  Europe PubMed DOI  V
  7. Behnam,M.A.M. and Klein,C.D.
    Alternate recognition by dengue protease: Proteolytic and binding assays provide functional evidence beyond an induced-fit
    Biochimie227, 15-27. PubMed  Europe PubMed DOI
  8. Cavina,L., Bouma,M.J., Girones,D. and Feiters,M.C.
    Orthoflaviviral Inhibitors in Clinical Trials, Preclinical In Vivo Efficacy Targeting NS2B-NS3 and Cellular Antiviral Activity via Competitive Protease Inhibition
    Molecules29, PubMed  Europe PubMed DOI  V  I
  9. Chongjun,Y., Nasr,A.M.S., Latif,M.A.M., Rahman,M.B.A., Marlisah,E. and Tejo,B.A.
    Predicting repurposed drugs targeting the NS3 protease of dengue virus using machine learning-based QSAR, molecular docking, and molecular dynamics simulations
    SAR QSAR Environ Res1-22. PubMed  Europe PubMed DOI
  10. Jitonnom,J., Meelua,W., Tue-Nguen,P., Saparpakorn,P., Hannongbua,S. and Chotpatiwetchkul,W.
    3D-QSAR and molecular docking studies of peptide-hybrids as dengue virus NS2B/NS3 protease inhibitors
    Chem Biol Interact396, 111040-111040. PubMed  Europe PubMed DOI
  11. Khalili,N.S.D., Khawory,M.H., Salin,N.H., Zakaria,I.I., Hariono,M., Mikhaylov,A.A., Kamarulzaman,E.E., Wahab,A., Supratman,U. and Nurul Azmi,M.
    Synthesis and biological activity of imidazole phenazine derivatives as potential inhibitors for NS2B-NS3 dengue protease
    Heliyon10, e24202-e24202. PubMed  Europe PubMed DOI  I
  12. Mushtaq,M., Siddiqui,A.R., Shafeeq,S., Khalid,A. and Ul-Haq,Z.
    Shifting paradigms: The promise of allosteric inhibitors against dengue virus protease
    Int J Biol Macromol282, 137056-137056. PubMed  Europe PubMed DOI  V
  13. Mustafa,N.F., Cheng,K.K., Nadri,M.H., Razali,S.A., Zakaria,I.I., Salin,N.H. and Amran,S.I.
    Discovery of azaleatin as a potential allosteric inhibitor for dengue NS2B-NS3 protease using in vitro and in silico studies
    J Biomol Struct Dyn1-12. PubMed  Europe PubMed DOI  I
  14. Serafim,M.S.M., Kronenberger,T., Rocha,R.E.O., Rosa,A.D.R.A., Mello,T.L.G., Poso,A., Ferreira,R.S., Abrahao,J.S., Kroon,E.G., Mota,B.E.F. and Maltarollo,V.G.
    Aminopyrimidine Derivatives as Multiflavivirus Antiviral Compounds Identified from a Consensus Virtual Screening Approach
    J Chem Inf Model64, 393-411. PubMed  Europe PubMed DOI
  15. Souza,B., Pontes,M., de,O.C., Sousa,F.d., Tizziani,T., Pollo,E., Dambros,B.P., Scotti,M.T., Steindel,M., Braga,A.L., Schirmeister,T., Assis,F.d. and Sandjo,L.P.
    Inhibitory Effects of Mangifera indica Secondary Metabolites and Their Synthetic Derivatives against SARS-CoV-2 M(pro) and NS2B/NS3 (ZIKV and DENV-2)
    ACS Omega9, 44624-44638. PubMed  Europe PubMed DOI
  16. Stalin,A., Han,J., Daniel Reegan,A., Ignacimuthu,S., Liu,S., Yao,X. and Zou,Q.
    Exploring the antiviral inhibitory activity of Niloticin against the NS2B/NS3 protease of Dengue virus (DENV2)
    Int J Biol Macromol133791-133791. PubMed  Europe PubMed DOI  I
  17. Starvaggi,J., Previti,S., Zappala,M. and Ettari,R.
    The Inhibition of NS2B/NS3 Protease: A New Therapeutic Opportunity to Treat Dengue and Zika Virus Infection
    Int J Mol Sci25, PubMed  Europe PubMed DOI
    18. 2023
  18. Agback,T., Lesovoy,D., Han,X., Lomzov,A., Sun,R., Sandalova,T., Orekhov,V.Y., Achour,A. and Agback,P.
    Combined NMR and molecular dynamics conformational filter identifies unambiguously dynamic ensembles of Dengue protease NS2B/NS3pro
    Commun Biol6, 1193-1193. PubMed  Europe PubMed DOI
  19. Coronado,M.A., Gering,I., Sevenich,M., Olivier,D.S., Mastalipour,M., Amaral,M.S., Willbold,D. and Eberle,R.J.
    The Importance of Epigallocatechin as a Scaffold for Drug Development against Flaviviruses
    Pharmaceutics15, PubMed  Europe PubMed DOI
  20. Gandhi,L., Maisnam,D., Rathore,D., Chauhan,P., Bonagiri,A. and Venkataramana,M.
    Differential localization of dengue virus protease affects cell homeostasis and triggers to thrombocytopenia
    iScience26, 107024-107024. PubMed  Europe PubMed DOI
  21. Incicco,J.J., Cababie,L.A., Sarto,C., Adler,N.S., Amrein,F., Mikkelsen,E., Arrar,M. and Kaufman,S.B.
    Thermodynamic and mechanistic analysis of the functional properties of dengue virus NS3 helicase
    Biophys Rev15, 591-600. PubMed  Europe PubMed DOI  V
  22. Maus,H., Hinze,G., Hammerschmidt,S.J., Basche,T. and Schirmeister,T.
    A competition smFRET assay to study ligand-induced conformational changes of the dengue virus protease
    Protein Sci32, e4526-e4526. PubMed  Europe PubMed DOI
  23. Misra,R., Maity,A., Kundu,S., Bhunia,M., Nanda,B., Maiti,N.C. and Pal,U.
    Loop Dynamics and Conformational Flexibility in Dengue Serine Protease Activity: Noninvasive Perturbation by Solvent Exchange
    J Chem Inf Model63, 2122-2132. PubMed  Europe PubMed DOI
  24. Teramoto,T.
    Dengue virus serotypic replacement of NS3 protease or helicase domain causes chimeric viral attenuation but can be recovered by a compensated mutation at helicase domain or NS2B, respectively
    J Virol97, e0085423-e0085423. PubMed  Europe PubMed DOI
  25. Wang,S.H., Kuo,B.J., Ho,T.C., Wan,S.W., Yen,K.L., Huang,P.H., Perng,O.G.C., Chen,P.L., Chien,Y.W. and Lo,Y.C.
    Lambda-free light chain: A serum marker of dengue disease via NS3 protease-mediated antibody cleavage
    Virulence14, 2279355-2279355. PubMed  Europe PubMed DOI
    26. 2022
  26. Bagga,T., Tulsian,N.K., Mok,Y.K., Kini,R.M. and Sivaraman,J.
    Mapping of molecular interactions between human E3 ligase TRIM69 and Dengue virus NS3 protease using hydrogen-deuterium exchange mass spectrometry
    Cell Mol Life Sci79, 233-233. PubMed  Europe PubMed DOI
  27. Cheng,J., Feng,S., Zhang,Y., Ding,T., Jiang,H., Zhang,Z., Wang,J., Wang,X. and Cheng,M.
    Discovery of highly potent DENV NS2B-NS3 covalent inhibitors containing a phenoxymethylphenyl residue
    Biochem Biophys Res Commun627, 214-219. PubMed  Europe PubMed DOI  I
  28. Dang,M., Lim,L., Roy,A. and Song,J.
    Myricetin Allosterically Inhibits the Dengue NS2B-NS3 Protease by Disrupting the Active and Locking the Inactive Conformations
    ACS Omega7, 2798-2808. PubMed  Europe PubMed DOI  I
  29. Hao,J., Li,J., Zhang,Z., Yang,Y., Zhou,Q., Wu,T., Chen,T., Wu,Z., Zhang,P., Cui,J. and Li,Y.P.
    NLRC5 restricts dengue virus infection by promoting the autophagic degradation of viral NS3 through E3 ligase CUL2 (cullin 2)
    Autophagy1-16. PubMed  Europe PubMed DOI
  30. Hasan,M., Mia,M.M., Munna,S.U., Talha,M.M.H. and Das,K.
    Seawater fungi-derived compound screening to identify novel small molecules against dengue virus NS5 methyltransferase and NS2B/NS3 protease
    Inform Med Unlocked30, 100932-100932. PubMed  Europe PubMed DOI
  31. Samrat,S.K., Xu,J., Li,Z., Zhou,J. and Li,H.
    Antiviral Agents against Flavivirus Protease: Prospect and Future Direction
    Pathogens11, PubMed  Europe PubMed DOI  V
    32. 2021
  32. Kai,Y., Lilan,X. and Yaoming,L.
    Monoclonal Antibody That Inhibits Cleavage Activity of Japanese Encephalitis Virus NS3
    Monoclon Antib Immunodiagn Immunother40, 28-32. PubMed  Europe PubMed DOI
  33. Kuhl,N., Leuthold,M.M., Behnam,M.A.M. and Klein,C.D.
    Beyond Basicity: Discovery of Nonbasic DENV-2 Protease Inhibitors with Potent Activity in Cell Culture
    J Med Chem64, 4567-4587. PubMed  Europe PubMed DOI  I
  34. Murtuja,S., Shilkar,D., Sarkar,B., Sinha,B.N. and Jayaprakash,V.
    A short survey of dengue protease inhibitor development in the past 6 years (2015-2020) with an emphasis on similarities between DENV and SARS-CoV-2 proteases
    Bioorg Med Chem49, 116415-116415. PubMed  Europe PubMed DOI  V
  35. Wahaab,A., Liu,K., Hameed,M., Anwar,M.N., Kang,L., Li,C., Ma,X., Wajid,A., Yang,Y., Khan,U.H., Wei,J., Li,B., Shao,D., Qiu,Y. and Ma,Z.
    Identification of Cleavage Sites Proteolytically Processed by NS2B-NS3 Protease in Polyprotein of Japanese Encephalitis Virus
    Pathogens10, PubMed  Europe PubMed DOI
    36. 2020
  36. Agback,P., Woestenenk,E. and Agback,T.
    Probing contacts of inhibitor locked in transition states in the catalytic triad of DENV2 type serine protease and its mutants by 1H, 19F and 15 N NMR spectroscopy
    BMC Mol Cell Biol21, 38-38. PubMed  Europe PubMed DOI  S  I
  37. Arias-Arias,J.L., MacPherson,D.J., Hill,M.E., Hardy,J.A. and Mora-Rodriguez,R.
    A fluorescence-activatable reporter of flavivirus NS2B-NS3 protease activity enables live imaging of infection in single cells and viral plaques
    J Biol Chem295, 2212-2226. PubMed  Europe PubMed DOI  A  L
  38. Drazic,T., Kopf,S., Corridan,J., Leuthold,M.M., Bertosa,B. and Klein,C.D.
    Peptide-beta-lactam inhibitors of dengue and West Nile virus NS2B-NS3 protease display two distinct binding modes
    J Med Chem63, 140-156. PubMed  Europe PubMed DOI  I
  39. Drazic,T., Kopf,S., Corridan,J., Leuthold,M.M., Bertosa,B. and Klein,C.D.
    Correction to Peptide-beta-lactam Inhibitors of Dengue and West Nile Virus NS2B-NS3 Protease Display Two Distinct Binding Modes
    J Med Chem63, 10530-10530. PubMed  Europe PubMed DOI
  40. Dwivedi,V.D., Bharadwaj,S., Afroz,S., Khan,N., Ansari,M.A., Yadava,U., Tripathi,R.C., Tripathi,I.P., Mishra,S.K. and Kang,S.G.
    Anti-dengue infectivity evaluation of bioflavonoid from Azadirachta indica by dengue virus serine protease inhibition
    J Biomol Struct Dyn1-14. PubMed  Europe PubMed DOI  I
  41. Gandikota,C., Gandhi,L., Maisnam,D., Kesavulu,M.M., Billoria,A., Prasad,V. and Venkataramana,M.
    A novel anti-NS2BNS3pro antibody-based indirect ELISA test for the diagnosis of dengue virus infections
    J Med Virol PubMed  Europe PubMed DOI
  42. Hamdani,S.S., Khan,B.A., Hameed,S., Batool,F., Saleem,H.N., Mughal,E.U. and Saeed,M.
    Synthesis and evaluation of novel S-benzyl- and S-alkylphthalimide- oxadiazole -benzenesulfonamide hybrids as inhibitors of dengue virus protease
    Bioorg Chem96, 103567-103567. PubMed  Europe PubMed DOI  I
  43. Holt,B.A. and Kwong,G.A.
    Protease circuits for processing biological information
    Nat Commun11, 5021-5021. PubMed  Europe PubMed DOI
  44. Kuhl,N., Graf,D., Bock,J., Behnam,M.A.M., Leuthold,M.M. and Klein,C.D.
    A New Class of Dengue and West Nile Virus Protease Inhibitors with Submicromolar Activity in Reporter Gene DENV-2 Protease and Viral Replication Assays
    J Med Chem PubMed  Europe PubMed DOI
  45. Li,Q. and Kang,C.
    Insights into structures and dynamics of flavivirus proteases from NMR studies
    Int J Mol Sci21, PubMed  Europe PubMed DOI  S
  46. Noske,G.D., Gawriljuk,V.O., Fernandes,R.S., Furtado,N.D., Bonaldo,M.C., Oliva,G. and Godoy,A.S.
    Structural characterization and polymorphism analysis of the NS2B-NS3 protease from the 2017 Brazilian circulating strain of Yellow Fever virus
    Biochim Biophys Acta Gen Subj1864, 129521-129521. PubMed  Europe PubMed DOI  S
  47. Phoo,W.W., El Sahili,A., Zhang,Z., Chen,M.W., Liew,C.W., Lescar,J., Vasudevan,S.G. and Luo,D.
    Crystal structures of full length DENV4 NS2B-NS3 reveal the dynamic interaction between NS2B and NS3
    Antiviral Res182, 104900-104900. PubMed  Europe PubMed DOI
  48. Rut,W., Groborz,K., Zhang,L., Modrzycka,S., Poreba,M., Hilgenfeld,R. and Drag,M.
    Profiling of flaviviral NS2B-NS3 protease specificity provides a structural basis for the development of selective chemical tools that differentiate Dengue from Zika and West Nile viruses
    Antiviral Res175, 104731-104731. PubMed  Europe PubMed DOI  P
  49. Shanmugam,A., Ramakrishnan,C., Velmurugan,D. and Gromiha,M.M.
    Identification of potential inhibitors for targets involved in Dengue fever
    Curr Top Med Chem20, 1742-1760. PubMed  Europe PubMed DOI
  50. Stanley,J.T., Gilchrist,A.R., Stabell,A.C., Allen,M.A., Sawyer,S.L. and Dowell,R.D.
    Two-stage ML classifier for identifying host protein targets of the dengue protease
    Pac Symp Biocomput25, 487-498. PubMed  Europe PubMed
    51. 2019
  51. Abdulrahman,A.Y., Rothan,H.A., Khazali,A.S., Teoh,T.C., Daher,A.M. and Yusof,R.
    Synthetic peptide optimization improves the inhibition of dengue NS2B-NS3 protease and dengue replication in vitro
    Acta Virol63, 278-285. PubMed  Europe PubMed DOI  I
  52. Chiramel,A.I., Meyerson,N.R., McNally,K.L., Broeckel,R.M., Montoya,V.R., Mendez-Solis,O., Robertson,S.J., Sturdevant,G.L., Lubick,K.J., Nair,V., Youseff,B.H., Ireland,R.M., Bosio,C.M., Kim,K., Luban,J., Hirsch,V.M., Taylor,R.T., Bouamr,F., Sawyer,S.L. and Best,S.M.
    TRIM5alpha Restricts Flavivirus Replication by Targeting the Viral Protease for Proteasomal Degradation
    Cell Rep27, 3269-3283. PubMed  Europe PubMed DOI
  53. da Silva-Junior,E.F. and de Araujo-Junior,J.X.
    Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses
    Bioorg Med Chem27, 3963-3978. PubMed  Europe PubMed DOI  I
  54. de Oliveira,A.S., Gazolla,P.A.R., Oliveira,A.F.C.D.S., Pereira,W.L., de S Viol,L.C., Maia,A.F.D.S., Santos,E.G., da Silva,I.E.P., Mendes,T.A.O., da Silva,A.M., Dias,R.S., da Silva,C.C., Poleto,M.D., Teixeira,R.R. and de Paula,S.O.
    Discovery of novel West Nile virus protease inhibitor based on isobenzonafuranone and triazolic derivatives of eugenol and indan-1,3-dione scaffolds
    PLoS ONE14, e0223017-e0223017. PubMed  Europe PubMed DOI  I
  55. Hariono,M., Choi,S.B., Roslim,R.F., Nawi,M.S., Tan,M.L., Kamarulzaman,E.E., Mohamed,N., Yusof,R., Othman,S., Abd Rahman,N., Othman,R. and Wahab,H.A.
    Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: virtual screening, synthesis, biological evaluation and molecular modelling
    PLoS ONE14, e0210869-e0210869. PubMed  Europe PubMed DOI  I
  56. Hill,M.E., Yildiz,M. and Hardy,J.A.
    Cysteine disulfide traps reveal distinct conformational ensembles in dengue virus NS2B-NS3 protease
    Biochemistry58, 776-787. PubMed  Europe PubMed DOI  S
  57. Jakob,A.K.M.H., Sundermann,T.R. and Klein,C.D.
    Backbone modifications in peptidic inhibitors of flaviviral proteases
    Bioorg Med Chem Lett29, 1913-1917. PubMed  Europe PubMed DOI  I
  58. Ji,M., Zhu,T., Xing,M., Luan,N., Mwangi,J., Yan,X., Mo,G., Rong,M., Li,B., Lai,R. and Jin,L.
    An antiviral peptide from Alopecosa nagpag spider targets NS2B-NS3 protease of flaviviruses
    Toxins (Basel)11, PubMed  Europe PubMed DOI  I
  59. Lim,L., Gupta,G., Roy,A., Kang,J., Srivastava,S., Shi,J. and Song,J.
    Structurally- and dynamically-driven allostery of the chymotrypsin-like proteases of SARS, Dengue and Zika viruses
    Prog Biophys Mol Biol143, 52-66. PubMed  Europe PubMed DOI  S
  60. Majerova,T., Novotny,P., Krysova,E. and Konvalinka,J.
    Exploiting the unique features of Zika and Dengue proteases for inhibitor design
    Biochimie166, 132-141. PubMed  Europe PubMed DOI  I
  61. Millies,B., von Hammerstein,F., Gellert,A., Hammerschmidt,S., Barthels,F., Goppel,U., Immerheiser,M., Elgner,F., Jung,N., Basic,M., Kersten,C., Kiefer,W., Bodem,J., Hildt,E., Windbergs,M., Hellmich,U.A. and Schirmeister,T.
    Proline-based allosteric inhibitors of Zika and Dengue virus NS2B/NS3 proteases
    J Med Chem62, 11359-11382. PubMed  Europe PubMed DOI  I
  62. Nitsche,C.
    Proteases from dengue, West Nile and Zika viruses as drug targets
    Biophys Rev11, 157-165. PubMed  Europe PubMed DOI  I
  63. Saw,W.G., Pan,A., Subramanian Manimekalai,M.S., Gruber,A. and Gruber,G.
    Structure and flexibility of non-structural proteins 3 and -5 of Dengue- and Zika viruses in solution
    Prog Biophys Mol Biol143, 67-77. PubMed  Europe PubMed DOI
  64. Sundermann,T.R., Benzin,C.V., Drazic,T. and Klein,C.D.
    Synthesis and structure-activity relationships of small-molecular di-basic esters, amides and carbamates as flaviviral protease inhibitors
    Eur J Med Chem176, 187-194. PubMed  Europe PubMed DOI  I
  65. Vishvakarma,V.K., Shukla,N., Reetu, Kumari,K., Patel,R. and Singh,P.
    A model to study the inhibition of nsP2B-nsP3 protease of dengue virus with imidazole, oxazole, triazole thiadiazole, and thiazolidine based scaffolds
    Heliyon5, e02124-e02124. PubMed  Europe PubMed DOI  I
  66. Yao,Y., Huo,T., Lin,Y.L., Nie,S., Wu,F., Hua,Y., Wu,J., Kneubehl,A.R., Vogt,M.B., Rico-Hesse,R. and Song,Y.
    Discovery, X-ray crystallography and antiviral activity of allosteric inhibitors of flavivirus NS2B-NS3 protease
    J Am Chem Soc141, 6832-6836. PubMed  Europe PubMed DOI  I
    67. 2018
  67. Agback,P. and Agback,T.
    Direct evidence of a low barrier hydrogen bond in the catalytic triad of a serine protease
    Sci Rep8, 10078-10078. PubMed  Europe PubMed DOI  S
  68. Beesetti,H., Tyagi,P., Medapi,B., Krishna,V.S., Sriram,D., Khanna,N. and Swaminathan,S.
    A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells
    Antivir Ther23, 385-394. PubMed  Europe PubMed DOI  I
  69. Chen,J., Jiang,H., Li,F., Hu,B., Wang,Y., Wang,M., Wang,J. and Cheng,M.
    Computational insight into dengue virus NS2B-NS3 protease inhibition: a combined ligand- and structure-based approach
    Comput Biol Chem77, 261-271. PubMed  Europe PubMed DOI  I
  70. Constant,D.A., Mateo,R., Nagamine,C.M. and Kirkegaard,K.
    Targeting intramolecular proteinase NS2B/3 cleavages for trans-dominant inhibition of dengue virus
    Proc Natl Acad Sci U S A115, 10136-10141. PubMed  Europe PubMed DOI  I
  71. Gibbs,A.C., Steele,R., Liu,G., Tounge,B.A. and Montelione,G.T.
    Inhibitor bound dengue NS2B-NS3pro reveals multiple dynamic binding modes
    Biochemistry57, 1591-1602. PubMed  Europe PubMed DOI  I
  72. Leonel,C.A., Lima,W.G., Dos Santos,M., Ferraz,A.C., Taranto,A.G., de Magalhaes,J.C., Dos Santos,L.L. and Ferreira,J.M.S.
    Pharmacophoric characteristics of dengue virus NS2B/NS3pro inhibitors: a systematic review of the most promising compounds
    Arch Virol163, 575-586. PubMed  Europe PubMed DOI  I
  73. Martinez,A.A., Espinosa,B.A., Adamek,R.N., Thomas,B.A., Chau,J., Gonzalez,E., Keppetipola,N. and Salzameda,N.T.
    Breathing new life into West Nile virus therapeutics; discovery and study of zafirlukast as an NS2B-NS3 protease inhibitor
    Eur J Med Chem157, 1202-1213. PubMed  Europe PubMed DOI  I
  74. O'Rourke,A., Kremb,S., Duggan,B.M., Sioud,S., Kharbatia,N., Raji,M., Emwas,A.H., Gerwick,W.H. and Voolstra,C.R.
    Identification of a 3-alkylpyridinium compound from the Red Sea sponge Amphimedon chloros with in vitro inhibitory activity against the West Nile virus NS3 protease
    Molecules23, PubMed  Europe PubMed DOI  I
  75. Oliveira,A.F.C.D.S., de Souza,A.P.M., de Oliveira,A.S., Da Silva,M.L., de Oliveira,F.M., Santos,E.G., da Silva,I.E.P., Ferreira,R.S., Villela,F.S., Martins,F.T., Leal,D.H.S., Vaz,B.G., Teixeira,R.R. and de Paula,S.O.
    Zirconium catalyzed synthesis of 2-arylidene Indan-1,3-diones and evaluation of their inhibitory activity against NS2B-NS3 WNV protease
    Eur J Med Chem149, 98-109. PubMed  Europe PubMed DOI  I
  76. Padmapriya,P., Gracy Fathima,S., Ramanathan,G., V,Y., A,K.S., Kaveri,K., Gunasekaran,P., Tirichurapalli Sivagnanam,U. and Thennarasu,S.
    Development of antiviral inhibitor against dengue 2 targeting Ns3 protein: In vitro and in silico significant studies
    Acta Trop188, 1-8. PubMed  Europe PubMed DOI  I
  77. Pinkham,A.M., Yu,Z. and Cowan,J.A.
    Broad-spectrum catalytic metallopeptide inactivators of Zika and West Nile virus NS2B/NS3 proteases
    Chem Commun (Camb)54, 12357-12360. PubMed  Europe PubMed DOI  I
  78. Sarwar,M.W., Riaz,A., Dilshad,S.M.R., al-Qahtani,A., Nawaz-Ul-Rehman,M.S. and Mubin,M.
    Structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) studies showed plant flavonoids as potential inhibitors of dengue NS2B-NS3 protease
    BMC Struct Biol18, 6-6. PubMed  Europe PubMed DOI  I
  79. Stabell,A.C., Meyerson,N.R., Gullberg,R.C., Gilchrist,A.R., Webb,K.J., Old,W.M., Perera,R. and Sawyer,S.L.
    Dengue viruses cleave STING in humans but not in nonhuman primates, their presumed natural reservoir
    elife7, PubMed  Europe PubMed DOI  P
  80. Yusufzai,S.K., Osman,H., Khan,M.S., Abd Razik,B.M., Ezzat,M.O., Mohamad,S., Sulaiman,O., Gansau,J.A. and Parumasivam,T.
    4-Thiazolidinone coumarin derivatives as two-component NS2B/NS3 DENV flavivirus serine protease inhibitors: synthesis, molecular docking, biological evaluation and structure-activity relationship studies
    Chem Cent J12, 69-69. PubMed  Europe PubMed DOI  I
    81. 2017
  81. Aguilera-Pesantes,D., Robayo,L.E., Mendez,P.E., Mollocana,D., Marrero-Ponce,Y., Torres,F.J. and Mendez,M.A.
    Discovering key residues of dengue virus NS2b-NS3-protease: new binding sites for antiviral inhibitors design
    Biochem Biophys Res Commun492, 631-642. PubMed  Europe PubMed DOI  I
  82. Aguirre,S., Luthra,P., Sanchez-Aparicio,M.T., Maestre,A.M., Patel,J., Lamothe,F., Fredericks,A.C., Tripathi,S., Zhu,T., Pintado-Silva,J., Webb,L.G., Bernal-Rubio,D., Solovyov,A., Greenbaum,B., Simon,V., Basler,C.F., Mulder,L.C., Garcia-Sastre,A. and Fernandez-Sesma,A.
    Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection
    Nat Microbiol2, 17037-17037. PubMed  Europe PubMed DOI
  83. Hsieh,M.S., Chen,M.Y., Hsieh,C.H., Pan,C.H., Yu,G.Y. and Chen,H.W.
    Detection and quantification of dengue virus using a novel biosensor system based on dengue NS3 protease activity
    PLoS ONE12, e0188170-e0188170. PubMed  Europe PubMed DOI  A
  84. Li,Z., Sakamuru,S., Huang,R., Brecher,M., Koetzner,C.A., Zhang,J., Chen,H., Qin,C.F., Zhang,Q.Y., Zhou,J., Kramer,L.D., Xia,M. and Li,H.
    Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease
    Antiviral Res150, 217-225. PubMed  Europe PubMed DOI  I
  85. Lin,K.H., Ali,A., Rusere,L., Soumana,D.I., Yilmaz,N.K. and Schiffer,C.A.
    Dengue virus NS2B/NS3 protease inhibitors exploiting the prime side
    J Virol91, e00045-17-e00045-17. PubMed  Europe PubMed DOI  I
  86. Liu,H., Zhang,L., Sun,J., Chen,W., Li,S., Wang,Q., Yu,H., Xia,Z., Jin,X. and Wang,C.
    Endoplasmic reticulum protein SCAP inhibits Dengue virus NS2B3 protease by suppressing its K27-linked polyubiquitylation
    J Virol91, e02234-16-e02234-16. PubMed  Europe PubMed DOI
  87. Mirza,S.B., Lee,R.C.H., Chu,J.J.H., Salmas,R.E., Mavromoustakos,T. and Durdagi,S.
    Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies
    J Mol Graph Model79, 88-102. PubMed  Europe PubMed DOI  I
  88. Nitsche,C., Zhang,L., Weigel,L.F., Schilz,J., Graf,D., Bartenschlager,R., Hilgenfeld,R. and Klein,C.D.
    Peptide-boronic acid inhibitors of flaviviral proteases: medicinal chemistry and structural biology
    J Med Chem60, 511-516. PubMed  Europe PubMed DOI  I
  89. Osman,H., Idris,N.H., Kamarulzaman,E.E., Wahab,H.A. and Hassan,M.Z.
    3,5-Bis(arylidene)-4-piperidones as potential dengue protease inhibitors
    Acta Pharm Sin B7, 479-484. PubMed  Europe PubMed DOI  A  I
  90. Pan,A., Saw,W.G., Subramanian Manimekalai,M.S., Gruber,A., Joon,S., Matsui,T., Weiss,T.M. and Gruber,G.
    Structural features of NS3 of Dengue virus serotypes 2 and 4 in solution and insight into RNA binding and the inhibitory role of quercetin
    Acta Crystallogr D Struct Biol73, 402-419. PubMed  Europe PubMed DOI  S
  91. Pathak,N., Lai,M.L., Chen,W.Y., Hsieh,B.W., Yu,G.Y. and Yang,J.M.
    Pharmacophore anchor models of flaviviral NS3 proteases lead to drug repurposing for DENV infection
    BMC Bioinformatics18, 548-548. PubMed  Europe PubMed DOI  I
  92. Qamar,M.T., Ashfaq,U.A., Tusleem,K., Mumtaz,A., Tariq,Q., Goheer,A. and Ahmed,B.
    In-silico identification and evaluation of plant flavonoids as dengue NS2B/NS3 protease inhibitors using molecular docking and simulation approach
    Pak J Pharm Sci30, 2119-2137. PubMed  Europe PubMed  I
  93. Schone,T., Grimm,L.L., Sakai,N., Zhang,L., Hilgenfeld,R. and Peters,T.
    STD-NMR experiments identify a structural motif with novel second-site activity against West Nile virus NS2B-NS3 protease
    Antiviral Res146, 174-183. PubMed  Europe PubMed DOI  I
  94. Takagi,Y., Matsui,K., Nobori,H., Maeda,H., Sato,A., Kurosu,T., Orba,Y., Sawa,H., Hattori,K., Higashino,K., Numata,Y. and Yoshida,Y.
    Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity
    Bioorg Med Chem Lett27, 3586-3590. PubMed  Europe PubMed DOI  I
  95. Weng,Z., Shao,X., Graf,D., Wang,C., Klein,C.D., Wang,J. and Zhou,G.C.
    Identification of fused bicyclic derivatives of pyrrolidine and imidazolidinone as dengue virus-2 NS2B-NS3 protease inhibitors
    Eur J Med Chem125, 751-759. PubMed  Europe PubMed DOI  I
  96. Woestenenk,E., Agback,P., Unnerstale,S., Henderson,I. and Agback,T.
    Co-refolding of a functional complex of Dengue NS3 protease and NS2B co-factor domain and backbone resonance assignment by solution NMR
    Protein Expr Purif140, 16-27. PubMed  Europe PubMed DOI  E
    97. 2016
  97. Ang,M.J., Lim,H.A., Poulsen,A., Wee,J.L., Ng,F.M., Joy,J., Hill,J. and Chia,C.S.
    Miniature bovine pancreatic trypsin inhibitors (m-BPTIs) of the West Nile virus NS2B-NS3 protease
    J Enzyme Inhib Med Chem31, 194-200. PubMed  Europe PubMed DOI  I
  98. Balasubramanian,A., Manzano,M., Teramoto,T., Pilankatta,R. and Padmanabhan,R.
    High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease
    Antiviral Res134, 6-16. PubMed  Europe PubMed DOI  I
  99. Dwivedi,V.D., Tripathi,I.P., Bharadwaj,S., Kaushik,A.C. and Mishra,S.K.
    Identification of new potent inhibitors of dengue virus NS3 protease from traditional Chinese medicine database
    Virusdisease27, 220-225. PubMed  Europe PubMed DOI  I
  100. Li,X.D., Deng,C.L., Ye,H.Q., Zhang,H.L., Zhang,Q.Y., Chen,D.D., Zhang,P.T., Shi,P.Y., Yuan,Z.M. and Zhang,B.
    Transmembrane domains of NS2B contribute to both viral rna replication and particle formation in Japanese encephalitis virus
    J Virol90, 5735-5749. PubMed  Europe PubMed DOI
  101. Liew,L.S., Lee,M.Y., Wong,Y.L., Cheng,J., Li,Q. and Kang,C.
    Selection of suitable detergents for obtaining an active dengue protease in its natural form from E. coli
    Protein Expr Purif121, 141-148. PubMed  Europe PubMed DOI  E
  102. Lima,M.C. and Seabra,G.M.
    Reaction mechanism of the dengue virus serine protease: a QM/MM study
    Phys Chem Chem Phys18, 30288-30296. PubMed  Europe PubMed DOI
  103. Lin,K.H., Nalivaika,E.A., Prachanronarong,K.L., Yilmaz,N.K. and Schiffer,C.A.
    Dengue protease substrate recognition: binding of the prime side
    ACS Infect Dis2, 734-743. PubMed  Europe PubMed DOI  P
  104. Mirza,S.B., Salmas,R.E., Fatmi,M.Q. and Durdagi,S.
    Virtual screening of eighteen million compounds against dengue virus: combined molecular docking and molecular dynamics simulations study
    J Mol Graph Model66, 99-107. PubMed  Europe PubMed DOI  I
  105. Shannon,A.E., Pedroso,M.M., Chappell,K.J., Watterson,D., Liebscher,S., Kok,W.M., Fairlie,D.P., Schenk,G. and Young,P.R.
    Product release is rate-limiting for catalytic processing by the Dengue virus protease
    Sci Rep6, 37539-37539. PubMed  Europe PubMed DOI  I
  106. Shannon,A.E., Chappell,K.J., Stoermer,M.J., Chow,S.Y., Kok,W.M., Fairlie,D.P. and Young,P.R.
    Simultaneous uncoupled expression and purification of the Dengue virus NS3 protease and NS2B co-factor domain
    Protein Expr Purif119, 124-129. PubMed  Europe PubMed DOI  E
  107. Tahirul Qamar,M., Kiran,S., Ashfaq,U.A., Javed,M.R., Anwar,F., Ali,M.A. and Gilani,A.H.
    Discovery of novel dengue NS2B/NS3 protease inhibitors using pharmacophore modeling and molecular docking based virtual screening of the ZINC database
    Int J Pharmacol12, 621-632. DOI  I
  108. Timiri,A.K., Sinha,B.N. and Jayaprakash,V.
    Progress and prospects on DENV protease inhibitors
    Eur J Med Chem117, 125-143. PubMed  Europe PubMed DOI  I
  109. Ulanday,G.E., Okamoto,K. and Morita,K.
    Development and utility of an in vitro, fluorescence-based assay for the discovery of novel compounds against dengue 2 viral protease
    Trop Med Health44, 22-22. PubMed  Europe PubMed DOI  A
    110. 2015
  110. Addis,S.N., Lee,E., Bettadapura,J. and Lobigs,M.
    Proteolytic cleavage analysis at the Murray Valley encephalitis virus NS1-2A junction
    Virol J12, 144-144. PubMed  Europe PubMed DOI
  111. Bastos Lima,A., Behnam,M.A., El Sherif,Y., Nitsche,C., Vechi,S.M. and Klein,C.D.
    Dual inhibitors of the dengue and West Nile virus NS2B-NS3 proteases: synthesis, biological evaluation and docking studies of novel peptide-hybrids
    Bioorg Med Chem23, 5748-5755. PubMed  Europe PubMed DOI  I
  112. Behnam,M.A.M., Graf,D., Bartenschlager,R., Zlotos,D.P. and Klein,C.D.
    Discovery of nanomolar dengue and West Nile virus protease inhibitors containing a 4-benzyloxyphenylglycine residue
    J Med Chem58, 9354-9370. PubMed  Europe PubMed DOI  I
  113. Chu,J.J., Lee,R.C., Ang,M.J., Wang,W.L., Lim,H.A., Wee,J.L., Joy,J., Hill,J. and Brian Chia,C.S.
    Antiviral activities of 15 dengue NS2B-NS3 protease inhibitors using a human cell-based viral quantification assay
    Antiviral Res118, 68-74. PubMed  Europe PubMed DOI  I
  114. De Sousa,L.R., Wu,H., Nebo,L., Fernandes,J.B., da Silva,M.F., Kiefer,W., Kanitz,M., Bodem,J., Diederich,W.E., Schirmeister,T. and Vieira,P.C.
    Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies
    Bioorg Med Chem23, 466-470. PubMed  Europe PubMed DOI  I
  115. Gupta,G., Lim,L. and Song,J.
    NMR and MD studies reveal that the isolated dengue NS3 protease is an intrinsically disordered chymotrypsin fold which absolutely requests NS2B for correct folding and functional dynamics
    PLoS ONE10, e0134823-e0134823. PubMed  Europe PubMed DOI
  116. Koh-Stenta,X., Joy,J., Wang,S.F., Kwek,P.Z., Wee,J.L., Wan,K.F., Gayen,S., Chen,A.S., Kang,C., Lee,M.A., Poulsen,A., Vasudevan,S.G., Hill,J. and Nacro,K.
    Identification of covalent active site inhibitors of dengue virus protease
    Drug Des Devel Ther9, 6389-6399. PubMed  Europe PubMed DOI  I
  117. Li,L., Basavannacharya,C., Chan,K.W., Shang,L., Vasudevan,S.G. and Yin,Z.
    Structure-guided discovery of a novel non-peptide inhibitor of dengue virus NS2B-NS3 protease
    Chem Biol Drug Des86, 255-264. PubMed  Europe PubMed DOI  I
  118. Pilla,K.B., Leman,J.K., Otting,G. and Huber,T.
    Capturing conformational States in proteins using sparse paramagnetic NMR data
    PLoS ONE10, e0127053- PubMed  Europe PubMed DOI
  119. Raut,R., Beesetti,H., Tyagi,P., Khanna,I., Jain,S.K., Jeankumar,V.U., Yogeeswari,P., Sriram,D. and Swaminathan,S.
    A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture
    Virol J12, 16-16. PubMed  Europe PubMed DOI  I
  120. Timiri,A.K., Selvarasu,S., Kesherwani,M., Vijayan,V., Sinha,B.N., Devadasan,V. and Jayaprakash,V.
    Synthesis and molecular modelling studies of novel sulphonamide derivatives as dengue virus 2 protease inhibitors
    Bioorg Chem62, 74-82. PubMed  Europe PubMed DOI  I
  121. VanBlargan,L.A., Davis,K.A., Dowd,K.A., Akey,D.L., Smith,J.L. and Pierson,T.C.
    Context-dependent cleavage of the capsid protein by the West Nile virus protease modulates the efficiency of virus assembly
    J Virol89, 8632-8642. PubMed  Europe PubMed DOI
  122. Verma,R., Jatav,V.K. and Sharma,S.
    Identification of inhibitors of dengue virus (Denv1, Denv2 and Denv3) NS2B/ NS3 serine protease: a molicular docking and simulation approach
    Asian J Pharm Clin Res8, 287-292.  I
  123. Weigel,L.F., Nitsche,C., Graf,D., Bartenschlager,R. and Klein,C.D.
    Phenylalanine and phenylglycine analogues as arginine mimetics in dengue protease inhibitors
    J Med Chem58, 7719-7733. PubMed  Europe PubMed DOI  I
  124. Wu,H., Bock,S., Snitko,M., Berger,T., Weidner,T., Holloway,S., Kanitz,M., Diederich,W.E., Steuber,H., Walter,C., Hofmann,D., Weissbrich,B., Spannaus,R., Acosta,E.G., Bartenschlager,R., Engels,B., Schirmeister,T. and Bodem,J.
    Novel Dengue virus NS2B/NS3 protease inhibitors
    Antimicrob Agents Chemother59, 1100-1109. PubMed  Europe PubMed DOI  I
  125. Yotmanee,P., Rungrotmongkol,T., Wichapong,K., Choi,S.B., Wahab,H.A., Kungwan,N. and Hannongbua,S.
    Binding specificity of polypeptide substrates in NS2B/NS3pro serine protease of dengue virus type 2: a molecular dynamics study
    J Mol Graph Model60, 24-33. PubMed  Europe PubMed DOI
  126. Yu,C.Y., Liang,J.J., Li,J.K., Lee,Y.L., Chang,B.L., Su,C.I., Huang,W.J., Lai,M.M. and Lin,Y.L.
    Dengue virus impairs mitochondrial fusion by cleaving mitofusins
    PLoS Pathog11, e1005350-e1005350. PubMed  Europe PubMed DOI
  127. Zhu,L., Yang,J., Li,H., Sun,H., Liu,J. and Wang,J.
    Conformational change study of dengue virus NS2B-NS3 protease using 19F NMR spectroscopy
    Biochem Biophys Res Commun461, 677-680. PubMed  Europe PubMed DOI
    128. 2014
  128. Ang,M.J., Li,Z., Lim,H.A., Ng,F.M., Then,S.W., Wee,J.L., Joy,J., Hill,J. and Chia,C.S.
    A P2 and P3 substrate specificity comparison between the Murray Valley encephalitis and West Nile virus NS2B/NS3 protease using C-terminal agmatine dipeptides
    Peptides52, 49-52. PubMed  Europe PubMed DOI  P
  129. Behnam,M.A., Nitsche,C., Vechi,S.M. and Klein,C.D.
    C-terminal residue optimization and fragment merging: discovery of a potent peptide-hybrid inhibitor of dengue protease
    ACS Med Chem Lett5, 1037-1042. PubMed  Europe PubMed DOI  I
  130. Chen,W.N., Loscha,K.V., Nitsche,C., Graham,B. and Otting,G.
    The dengue virus NS2B-NS3 protease retains the closed conformation in the complex with BPTI
    FEBS Lett588, 2206-2211. PubMed  Europe PubMed DOI
  131. de la Cruz,L., Chen,W.N., Graham,B. and Otting,G.
    Binding mode of the activity-modulating C-terminal segment of NS2B to NS3 in the dengue virus NS2B-NS3 protease
    FEBS J281, 1517-1533. PubMed  Europe PubMed DOI
  132. Idrees,S. and Ashfaq,U.A.
    Discovery and design of cyclic peptides as dengue virus inhibitors through structure-based molecular docking
    Asian Pac J Trop Med7, 513-516. PubMed  Europe PubMed DOI  I
  133. Lai,H., Teramoto,T. and Padmanabhan,R.
    Construction of dengue virus protease expression plasmid and in vitro protease assay for screening antiviral inhibitors
    Methods Mol Biol1138, 345-360. PubMed  Europe PubMed DOI  E  I
  134. Li,H., Zhu,L., Hou,S., Yang,J., Wang,J. and Liu,J.
    An inhibition model of BPTI to unlinked dengue virus NS2B-NS3 protease
    FEBS Lett588, 2794-2799. PubMed  Europe PubMed DOI  S
  135. Lin,J.C., Lin,S.C., Chen,W.Y., Yen,Y.T., Lai,C.W., Tao,M.H., Lin,Y.L., Miaw,S.C. and Wu-Hsieh,B.A.
    Dengue Viral Protease Interaction with NF-kappaB Inhibitor alpha/beta Results in Endothelial Cell Apoptosis and Hemorrhage Development
    J Immunol193, 1258-1267. PubMed  Europe PubMed DOI
  136. Liu,H., Wu,R., Sun,Y., Ye,Y., Chen,J., Luo,X., Shen,X. and Liu,H.
    Identification of novel thiadiazoloacrylamide analogues as inhibitors of dengue-2 virus NS2B/NS3 protease
    Bioorg Med Chem22, 6344-6352. PubMed  Europe PubMed DOI  I
  137. Manzano,M., Padia,J. and Padmanabhan,R.
    Small molecule inhibitor discovery for dengue virus protease using high-throughput screening
    Methods Mol Biol1138, 331-344. PubMed  Europe PubMed DOI  I
  138. Mukhametov,A., Newhouse,E.I., Aziz,N.A., Saito,J.A. and Alam,M.
    Allosteric pocket of the dengue virus (serotype 2) NS2B/NS3 protease: in silico ligand screening and molecular dynamics studies of inhibition
    J Mol Graph Model52, 103-113. PubMed  Europe PubMed DOI  I
  139. Nitsche,C., Holloway,S., Schirmeister,T. and Klein,C.D.
    Biochemistry and medicinal chemistry of the dengue virus protease
    Chem Rev114, 11348-11381. PubMed  Europe PubMed DOI  V
  140. Poulsen,A., Kang,C. and Keller,T.H.
    Drug design for flavivirus proteases: what are we missing?
    Curr Pharm Des20, 3422-3427. PubMed  Europe PubMed DOI  I
  141. Qamar,T.U., Mumtaz,A., Ashfaq,U.A., Azhar,S., Fatima,T., Hassan,M., Hussain,S.S., Akram,W. and Idrees,S.
    Computer aided screening of phytochemicals from Garcinia against the dengue NS2B/NS3 protease
    Bioinformation10, 115-118. PubMed  Europe PubMed DOI  I
  142. Velmurugan,D., Mythily,U. and Rao,K.
    Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus NS2B/NS3 protease
    Protein Pept Lett21, 815-827. PubMed  Europe PubMed  I
  143. Viswanathan,U., Tomlinson,S.M., Fonner,J.M., Mock,S.A. and Watowich,S.J.
    Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery web portal
    J Chem Inf Model54, 2816-2825. PubMed  Europe PubMed DOI  I
  144. Zhou,J., Wang,X., Pei,C., Song,Y. and Chen,H.
    Method for Japanese encephalitis virus NS3 protease activity analysis and high-throughput screening assay for inhibitors
    Sheng Wu Gong Cheng Xue Bao30, 194-202. DOI  A  I
    145. 2013
  145. Adamek,R.N., Maniquis,R.V., Khakoo,S., Bridges,M.D. and Salzameda,N.T.
    A FRET-based assay for the discovery of West Nile virus NS2B-NS3 protease inhibitors
    Bioorg Med Chem Lett23, 4848-4850. PubMed  Europe PubMed DOI  A
  146. Ang,M.J., Yong,G.H., Poulsen,A., Then,S.W., Li,Z., Joy,J., Hill,J. and Chia,C.S.
    Substrate-based peptidomimetic inhibitors of the Murray Valley encephalitis virus NS2B/NS3 serine protease: a P1-P4 SAR study
    Eur J Med Chem68, 72-80. PubMed  Europe PubMed DOI  A
  147. Ayub,A., Ashfaq,U.A., Idrees,S. and Haque,A.
    Global consensus sequence development and analysis of dengue NS3 conserved domains
    Biores Open Access2, 392-396. PubMed  Europe PubMed DOI
  148. Bi,Y., Zhu,L., Li,H., Wu,B., Liu,J. and Wang,J.
    Backbone 1H, 13C and 15N resonance assignments of dengue virus NS2B-NS3p in complex with aprotinin
    Biomol NMR Assign7, 137-139. PubMed  Europe PubMed DOI  S
  149. Brecher,M., Zhang,J. and Li,H.
    The flavivirus protease as a target for drug discovery
    Virol Sin28, 326-336. PubMed  Europe PubMed DOI  I
  150. de Almeida,H., Bastos,I.M., Ribeiro,B.M., Maigret,B. and Santana,J.M.
    New binding site conformations of the dengue virus NS3 protease accessed by molecular dynamics simulation
    PLoS ONE8, e72402-e72402. PubMed  Europe PubMed DOI
  151. Gao,Y., Samanta,S., Cui,T. and Lam,Y.
    Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 1,3,4,5-tetrasubstituted 1H-pyrrol-2(5H)-one scaffold
    ChemMedChem8, 1554-1560. PubMed  Europe PubMed DOI  I
  152. Garces,A.P. and Watowich,S.J.
    Intrinsic flexibility of West Nile virus protease in solution characterized using small-angle X-ray scattering
    Biochemistry52, 6856-6865. PubMed  Europe PubMed DOI  S
  153. Hammamy,M.Z., Haase,C., Hammami,M., Hilgenfeld,R. and Steinmetzer,T.
    Development and characterization of new peptidomimetic inhibitors of the west Nile virus NS2B-NS3 protease
    ChemMedChem8, 231-241. PubMed  Europe PubMed DOI  S  I
  154. Heh,C.H., Othman,R., Buckle,M.J., Sharifuddin,Y., Yusof,R. and Rahman,N.A.
    Rational discovery of dengue type 2 non-competitive inhibitors
    Chem Biol Drug Des82, 1-11. PubMed  Europe PubMed DOI  I
  155. Huang,Q., Li,Q., Joy,J., Chen,A.S., Ruiz-Carrillo,D., Hill,J., Lescar,J. and Kang,C.
    Lyso-myristoyl phosphatidylcholine micelles sustain the activity of Dengue non-structural (NS) protein 3 protease domain fused with the full-length NS2B
    Protein Expr Purif92, 156-162. PubMed  Europe PubMed DOI  E
  156. Jia,F., Fan,J., Zhang,B. and Yuan,Z.
    Mutagenesis of D80-82 and G83 residues in West Nile virus NS2B: effects on NS2B-NS3 activity and viral replication
    Virol Sin28, 16-23. PubMed  Europe PubMed DOI
  157. Junaid,M., Angsuthanasombat,C., Wikberg,J.E.S., Ali,N. and Katzenmeier,G.
    A straightforward experimental approach to expression, purification, refolding, and enzymatic analysis of recombinant dengue virus NS2B(H)-NS3pro protease
    Biochemistry (Mosc)78, 920-924. PubMed  Europe PubMed DOI  E
  158. Kang,C., Gayen,S., Wang,W., Severin,R., Chen,A.S., Lim,H.A., Chia,C.S., Schuller,A., Doan,D.N., Poulsen,A., Hill,J., Vasudevan,S.G. and Keller,T.H.
    Exploring the binding of peptidic West Nile virus NS2B-NS3 protease inhibitors by NMR
    Antiviral Res97, 137-144. PubMed  Europe PubMed DOI  I
  159. Kim,Y.M., Gayen,S., Kang,C., Joy,J., Huang,Q., Chen,A.S., Wee,J.L., Ang,M.J., Lim,H.A., Hung,A.W., Li,R., Noble,C.G., Lee,l.T., Yip,A., Wang,Q.Y., Chia,C.S., Hill,J., Shi,P.Y. and Keller,T.H.
    NMR analysis of a novel enzymatically active unlinked Dengue NS2B-NS3 protease complex
    J Biol Chem288, 12891-12900. PubMed  Europe PubMed DOI
  160. Lai,H., Sridhar Prasad,G. and Padmanabhan,R.
    Characterization of 8-hydroxyquinoline derivatives containing aminobenzothiazole as inhibitors of dengue virus type 2 protease in vitro
    Antiviral Res97, 74-80. PubMed  Europe PubMed DOI  I
  161. Lai,H., Dou,D., Aravapalli,S., Teramoto,T., Lushington,G.H., Mwania,T.M., Alliston,K.R., Eichhorn,D.M., Padmanabhan,R. and Groutas,W.C.
    Design, synthesis and characterization of novel 1,2-benzisothiazol-3(2H)-one and 1,3,4-oxadiazole hybrid derivatives: potent inhibitors of Dengue and West Nile virus NS2B/NS3 proteases
    Bioorg Med Chem21, 102-113. PubMed  Europe PubMed DOI  I
  162. Lim,H.A., Ang,M.J., Joy,J., Poulsen,A., Wu,W., Ching,S.C., Hill,J. and Chia,C.S.
    Novel agmatine dipeptide inhibitors against the West Nile virus NS2B/NS3 protease: A P3 and N-cap optimization study
    Eur J Med Chem62, 199-205. PubMed  Europe PubMed DOI  I
  163. Nguyen,T.T., Lee,S., Wang,H.K., Chen,H.Y., Wu,Y.T., Lin,S.C., Kim,D.W. and Kim,D.
    In vitro evaluation of novel inhibitors against the NS2B-NS3 protease of dengue fever virus type 4
    Molecules18, 15600-15612. PubMed  Europe PubMed DOI  I
  164. Nitsche,C. and Klein,C.D.
    Fluorimetric and HPLC-based dengue virus protease assays using a FRET substrate
    Methods Mol Biol1030, 221-236. PubMed  Europe PubMed DOI  A
  165. Nitsche,C., Schreier,V.N., Behnam,M.A., Kumar,A., Bartenschlager,R. and Klein,C.D.
    Thiazolidinone-peptide hybrids as dengue virus protease inhibitors with antiviral activity in cell culture
    J Med Chem56, 8389-8403. PubMed  Europe PubMed DOI  I
  166. Pambudi,S., Kawashita,N., Phanthanawiboon,S., Omokoko,M.D., Masrinoul,P., Yamashita,A., Limkittikul,K., Yasunaga,T., Takagi,T., Ikuta,K. and Kurosu,T.
    A small compound targeting the interaction between nonstructural proteins 2B and 3 inhibits dengue virus replication
    Biochem Biophys Res Commun440, 393-398. PubMed  Europe PubMed DOI  I
  167. Parida,P., Yadav,R.N., Sarma,K. and Nainwal,L.M.
    Design, virtual screening and docking study of novel NS3 inhibitors by targeting protein-protein interacting sites of dengue virus - a novel approach
    Curr Pharm Biotechnol14, 995-1008. PubMed  Europe PubMed DOI  I
  168. Rothan,H.A., Mohamed,Z., Suhaeb,A.M., Rahman,N.A. and Yusof,R.
    Antiviral cationic peptides as a strategy for innovation in global health therapeutics for dengue virus: high yield production of the biologically active recombinant plectasin peptide
    OMICS17, 560-567. PubMed  Europe PubMed DOI  I
  169. Samanta,S., Lim,T.L. and Lam,Y.
    Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 2-{6-[2-(5-Phenyl-4H-{1,2,4]triazol-3-ylsulfanyl)acetylamino]benzothiazol-2-ylsulfanyl}acetamide scaffold
    ChemMedChem8, 994-1001. PubMed  Europe PubMed DOI  I
  170. Saparpakorn,P., Kobayashi,M. and Nakai,H.
    Divide-and-conquer electronic-structure study on the mechanism of the West Nile virus NS3 protease inhibitor
    Bull Chem Soc Jpn86, 67-74. DOI  I
  171. Senthilvel,P., Lavanya,P., Kumar,K.M., Swetha,R., Anitha,P., Bag,S., Sarveswari,S., Vijayakumar,V., Ramaiah,S. and Anbarasu,A.
    Flavonoid from Carica papaya inhibits NS2B-NS3 protease and prevents dengue 2 viral assembly
    Bioinformation9, 889-895. PubMed  Europe PubMed DOI  I
  172. Wichapong,K., Nueangaudom,A., Pianwanit,S., Sippl,W. and Kokpol,S.
    Identification of potential hit compounds for dengue virus NS2B/NS3 protease inhibitors by combining virtual screening and binding free energy calculations
    Trop Biomed30, 388-408. PubMed  Europe PubMed  I
  173. Yildiz,M., Ghosh,S., Bell,J.A., Sherman,W. and Hardy,J.A.
    Allosteric inhibition of the NS2B-NS3 protease from dengue virus
    ACS Chem Biol8, 2744-2752. PubMed  Europe PubMed DOI  I
    174. 2012
  174. Aguirre,S., Maestre,A.M., Pagni,S., Patel,J.R., Savage,T., Gutman,D., Maringer,K., Bernal-Rubio,D., Shabman,R.S., Simon,V., Rodriguez-Madoz,J.R., Mulder,L.C., Barber,G.N. and Fernandez-Sesma,A.
    DENV inhibits type I IFN production in infected cells by cleaving human STING
    PLoS Pathog8, e1002934-e1002934. PubMed  Europe PubMed DOI  P
  175. Aravapalli,S., Lai,H., Teramoto,T., Alliston,K.R., Lushington,G.H., Ferguson,E.L., Padmanabhan,R. and Groutas,W.C.
    Inhibitors of Dengue virus and West Nile virus proteases based on the aminobenzamide scaffold
    Bioorg Med Chem20, 4140-4148. PubMed  Europe PubMed DOI  I
  176. Choksupmanee,O., Hodge,K., Katzenmeier,G. and Chimnaronk,S.
    Structural platform for the autolytic activity of an intact NS2B-NS3 protease complex from dengue virus
    Biochemistry51, 2840-2851. PubMed  Europe PubMed DOI
  177. Deng,J., Li,N., Liu,H., Zuo,Z., Liew,O.W., Xu,W., Chen,G., Tong,X., Tang,W., Zhu,J., Zuo,J., Jiang,H., Yang,C.G., Li,J. and Zhu,W.
    Discovery of novel small molecule inhibitors of Dengue viral NS2B-NS3 protease using virtual screening and scaffold hopping
    J Med Chem55, 6278-6293. PubMed  Europe PubMed DOI  I
  178. Doan,D.N., Li,K.Q., Basavannacharya,C., Vasudevan,S.G. and Madhusudhan,M.S.
    Transplantation of a hydrogen bonding network from West Nile virus protease onto Dengue-2 protease improves catalytic efficiency and sheds light on substrate specificity
    Protein Eng Des Sel25, 843-850. PubMed  Europe PubMed DOI  P
  179. Ede,N.J., Hill,J., Joy,J.K., Ede,A.M. and Koppens,M.L.
    Solid-phase synthesis and screening of a library of C-terminal arginine peptide aldehydes against Murray Valley encephalitis virus protease
    J Pept Sci18, 661-668. PubMed  Europe PubMed DOI  I
  180. Ezgimen,M., Lai,H., Mueller,N.H., Lee,K., Cuny,G., Ostrov,D.A. and Padmanabhan,R.
    Characterization of the 8-hydroxyquinoline scaffold for inhibitors of West Nile virus serine protease
    Antiviral Res94, 18-24. PubMed  Europe PubMed DOI  I
  181. Gayen,S., Chen,A.S., Huang,Q. and Kang,C.
    West Nile virus (WNV) protease and membrane interactions revealed by NMR spectroscopy
    Biochem Biophys Res Commun423, 799-804. PubMed  Europe PubMed DOI
  182. Huang,D.
    High-throughput virtual screening lead to discovery of non-peptidic inhibitors of west nile virus NS3 protease
    Methods Mol Biol819, 615-623. PubMed  Europe PubMed DOI  I
  183. Junaid,M., Chalayut,C., Sehgelmeble Torrejon,A., Angsuthanasombat,C., Shutava,I., Lapins,M., Wikberg,J.E. and Katzenmeier,G.
    Enzymatic analysis of recombinant Japanese encephalitis virus NS2B(H)-NS3pro protease with fluorogenic model peptide substrates
    PLoS ONE7, e36872-e36872. PubMed  Europe PubMed DOI  A  E
  184. Kummerer,B.M., Amberg,S.M. and Rice,C.M.
    Flavivirin
    [ISSN:978-0-12-407742-3]3, 3112-3120. DOI
  185. Kurz,M., Stefan,N., Zhu,J. and Skern,T.
    NS2B/3 proteolysis at the C-prM junction of the tick-borne encephalitis virus polyprotein is highly membrane dependent
    Virus Res168, 48-55. PubMed  Europe PubMed DOI
  186. Nitsche,C., Behnam,M.A., Steuer,C. and Klein,C.D.
    Retro peptide-hybrids as selective inhibitors of the Dengue virus NS2B-NS3 protease
    Antiviral Res94, 72-79. PubMed  Europe PubMed DOI  I
  187. Noble,C.G., Seh,C.C., Chao,A.T. and Shi,P.Y.
    Ligand-bound structures of the dengue virus protease reveal the active conformation
    J Virol86, 438-446. PubMed  Europe PubMed DOI  S
  188. Noble,C.G. and Shi,P.Y.
    Structural biology of dengue virus enzymes: towards rational design of therapeutics
    Antiviral Res96, 115-126. PubMed  Europe PubMed DOI  S
  189. Potapova,U.V., Feranchuk,S.I., Potapov,V.V., Kulakova,N.V., Kondratov,I.G., Leonova,G.N. and Belikov,S.I.
    NS2B/NS3 protease: allosteric effect of mutations associated with the pathogenicity of tick-borne encephalitis virus
    J Biomol Struct Dyn30, 638-651. PubMed  Europe PubMed DOI
  190. Rothan,H.A., Abdulrahman,A.Y., Sasikumer,P.G., Othman,S., Abd Rahman,N. and Yusof,R.
    Protegrin-1 inhibits dengue NS2B-NS3 serine protease and viral replication in MK2 cells
    J Biomed Biotechnol2012, 251482-251482. PubMed  Europe PubMed DOI  I
  191. Rothan,H.A., Han,H.C., Ramasamy,T.S., Othman,S., Rahman,N.A. and Yusof,R.
    Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1
    BMC Infect Dis12, 314-314. PubMed  Europe PubMed DOI  I
  192. Samanta,S., Cui,T. and Lam,Y.
    Discovery, synthesis, and in vitro evaluation of West Nile virus protease inhibitors based on the 9,10-dihydro-3h,4ah-1,3,9,10a-tetraazaphenanthren-4-one scaffold
    ChemMedChem7, 1210-1216. PubMed  Europe PubMed DOI  I
  193. Tiew,K.C., Dou,D., Teramoto,T., Lai,H., Alliston,K.R., Lushington,G.H., Padmanabhan,R. and Groutas,W.C.
    Inhibition of Dengue virus and West Nile virus proteases by click chemistry-derived benz[d]isothiazol-3(2H)-one derivatives
    Bioorg Med Chem20, 1213-1221. PubMed  Europe PubMed DOI  I
  194. Tomlinson,S.M. and Watowich,S.J.
    Use of parallel validation high-throughput screens to reduce false positives and identify novel dengue NS2B-NS3 protease inhibitors
    Antiviral Res93, 245-252. PubMed  Europe PubMed DOI  I
  195. Xu,S., Li,H., Shao,X., Fan,C., Ericksen,B., Liu,J., Chi,C. and Wang,C.
    Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease
    J Med Chem55, 6881-6887. PubMed  Europe PubMed DOI  I
    196. 2011
  196. Cregar-Hernandez,L., Jiao,G.S., Johnson,A.T., Lehrer,A.T., Wong,T.A. and Margosiak,S.A.
    Small molecule pan-dengue and West Nile virus NS3 protease inhibitors
    Antivir Chem Chemother21, 209-217. PubMed  Europe PubMed DOI  I
  197. Frimayanti,N., Chee,C.F., Zain,S.M. and Rahman,N.A.
    Design of new competitive dengue Ns2b/Ns3 protease inhibitors - a computational approach
    Int J Mol Sci12, 1089-1100. PubMed  Europe PubMed DOI  I
  198. Kannappan,P. and Narayanan,S.
    Mutation and docking studies on NS2b-NS3 complex from yellow fever virus towards drug discovery
    Bioinformation6, 303-306. PubMed  Europe PubMed
  199. Knehans,T., Schuller,A., Doan,D.N., Nacro,K., Hill,J., Guntert,P., Madhusudhan,M.S., Weil,T. and Vasudevan,S.G.
    Structure-guided fragment-based in silico drug design of dengue protease inhibitors
    J Comput Aided Mol Des25, 263-274. PubMed  Europe PubMed DOI  I
  200. Kondo,M.Y., Oliveira,L.C., Okamoto,D.N., de Araujo,M.R., Duarte Dos Santos,C.N., Juliano,M.A., Juliano,L. and Gouvea,I.E.
    Yellow fever virus NS2B/NS3 protease: hydrolytic properties and substrate specificity
    Biochem Biophys Res Commun407, 640-644. PubMed  Europe PubMed DOI  A  P
  201. Lim,H.A., Joy,J., Hill,J. and San Brian Chia,C.
    Novel agmatine and agmatine-like peptidomimetic inhibitors of the West Nile virus NS2B/NS3 serine protease
    Eur J Med Chem46, 3130-3134. PubMed  Europe PubMed DOI  I
  202. Nitsche,C., Steuer,C. and Klein,C.D.
    Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases
    Bioorg Med Chem19, 7318-7337. PubMed  Europe PubMed DOI  I
  203. Phong,W.Y., Moreland,N.J., Lim,S.P., Wen,D., Paradkar,P.N. and Vasudevan,S.G.
    Dengue protease activity: the structural integrity and interaction of NS2B with NS3 protease and its potential as a drug target
    Biosci Rep31, 399-409. PubMed  Europe PubMed DOI
  204. Schuller,A., Yin,Z., Brian Chia,C.S., Doan,D.N., Kim,H.K., Shang,L., Loh,T.P., Hill,J. and Vasudevan,S.G.
    Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease
    Antiviral Res92, 96-101. PubMed  Europe PubMed DOI  I
  205. Shiryaev,S.A., Cheltsov,A.V., Gawlik,K., Ratnikov,B.I. and Strongin,A.Y.
    Virtual ligand screening of the National Cancer Institute (NCI) compound library leads to the allosteric inhibitory scaffolds of the West Nile virus NS3 proteinase
    Assay Drug Dev Technol9, 69-78. PubMed  Europe PubMed DOI  I
  206. Steuer,C., Gege,C., Fischl,W., Heinonen,K.H., Bartenschlager,R. and Klein,C.D.
    Synthesis and biological evaluation of alpha-ketoamides as inhibitors of the Dengue virus protease with antiviral activity in cell-culture
    Bioorg Med Chem19, 4067-4074. PubMed  Europe PubMed DOI  I
  207. Tambunan,U.S., Apriyanti,N., Parikesit,A.A., Chua,W. and Wuryani,K.
    Computational design of disulfide cyclic peptide as potential inhibitor of complex NS2B-NS3 dengue virus protease
    Afr J Biotechnol10, 12281-12290.  I
  208. Tomlinson,S.M. and Watowich,S.J.
    Anthracene-based inhibitors of dengue virus NS2B-NS3 protease
    Antiviral Res89, 127-135. PubMed  Europe PubMed DOI  I
  209. Yang,C.C., Hsieh,Y.C., Lee,S.J., Wu,S.H., Liao,C.L., Tsao,C.H., Chao,Y.S., Chern,J.H., Wu,C.P. and Yueh,A.
    Novel dengue virus-specific NS2B/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay
    Antimicrob Agents Chemother55, 229-238. PubMed  Europe PubMed DOI  I
    210. 2010
  210. Chandramouli,S., Joseph,J.S., Daudenarde,S., Gatchalian,J., Cornillez-Ty,C. and Kuhn,P.
    Serotype-specific structural differences in the protease-cofactor complexes of the Dengue virus family
    J Virol84, 3059-3067. PubMed  Europe PubMed DOI  S
  211. Condotta,S.A., Martin,M.M., Boutin,M. and Jean,F.
    Detection and in-cell selectivity profiling of the full-length West Nile virus NS2B/NS3 serine protease using membrane-anchored fluorescent substrates
    Biol Chem391, 549-559. PubMed  Europe PubMed DOI  A
  212. Dou,D., Viwanathan,P., Li,Y., He,G., Alliston,K.R., Lushington,G.H., Brown-Clay,J.D., Padmanabhan,R. and Groutas,W.C.
    Design, synthesis, and in vitro evaluation of potential West Nile virus protease inhibitors based on the 1-oxo-1,2,3,4-tetrahydroisoquinoline and 1-oxo-1,2-dihydroisoquinoline scaffolds
    J Comb Chem12, 836-843. PubMed  Europe PubMed DOI  I
  213. Frecer,V. and Miertus,S.
    Design, structure-based focusing and in silico screening of combinatorial library of peptidomimetic inhibitors of Dengue virus NS2B-NS3 protease
    J Comput Aided Mol Des24, 195-212. PubMed  Europe PubMed DOI  I
  214. Joy,J., Mee,N.F., Kuan,W.L., Perlyn,K.Z., Wen,T.S. and Hill,J.
    Biochemical characterisation of Murray Valley encephalitis virus proteinase
    FEBS Lett584, 3149-3152. PubMed  Europe PubMed DOI
  215. Rodriguez-Madoz,J.R., Belicha-Villanueva,A., Bernal-Rubio,D., Ashour,J., Ayllon,J. and Fernandez-Sesma,A.
    Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex
    J Virol84, 9760-9774. PubMed  Europe PubMed DOI
  216. Salaemae,W., Junaid,M., Angsuthanasombat,C. and Katzenmeier,G.
    Structure-guided mutagenesis of active site residues in the dengue virus two-component protease NS2B-NS3
    J Biomed Sci17, 68-68. PubMed  Europe PubMed DOI  E
  217. Shiryaev,S.A. and Strongin,A.Y.
    Structural and functional parameters of the flaviviral protease: a promising antiviral drug target
    Future Virol5, 593-606. PubMed  Europe PubMed DOI  T
  218. Shiryaev,S.A., Radichev,I.A., Ratnikov,B.I., Aleshin,A.E., Gawlik,K., Stec,B., Frisch,C., Knappik,A. and Strongin,A.Y.
    Isolation and characterization of selective and potent human Fab inhibitors directed to the active-site region of the two-component NS2B-NS3 proteinase of West Nile virus
    Biochem J427, 369-376. PubMed  Europe PubMed DOI
  219. Steuber,H. and Hilgenfeld,R.
    Recent advances in targeting viral proteases for the discovery of novel antivirals
    Curr Top Med Chem10, 323-345. PubMed  Europe PubMed DOI  V
  220. Wichapong,K., Pianwanit,S., Sippl,W. and Kokpol,S.
    Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction
    J Mol Recognit23, 283-300. PubMed  Europe PubMed DOI
    221. 2009
  221. Assenberg,R., Mastrangelo,E., Walter,T.S., Verma,A., Milani,M., Owens,R.J., Stuart,D.I., Grimes,J.M. and Mancini,E.J.
    Crystal structure of a novel conformational state of the flavivirus NS3 protein: implications for polyprotein processing and viral replication
    J Virol83, 12895-12906. PubMed  Europe PubMed DOI  S
  222. Bodenreider,C., Beer,D., Keller,T.H., Sonntag,S., Wen,D., Yap,L., Yau,Y.H., Shochat,S.G., Huang,D., Zhou,T., Caflisch,A., Su,X.C., Ozawa,K., Otting,G., Vasudevan,S.G., Lescar,J. and Lim,S.P.
    A fluorescence quenching assay to discriminate between specific and nonspecific inhibitors of dengue virus protease
    Anal Biochem395, 195-204. PubMed  Europe PubMed DOI  A
  223. Ekonomiuk,D. and Caflisch,A.
    Activation of the West Nile virus NS3 protease: molecular dynamics evidence for a conformational selection mechanism
    Protein Sci18, 1003-1011. PubMed  Europe PubMed DOI
  224. Ekonomiuk,D., Su,X.C., Ozawa,K., Bodenreider,C., Lim,S.P., Otting,G., Huang,D. and Caflisch,A.
    Flaviviral protease inhibitors identified by fragment-based library docking into a structure generated by molecular dynamics
    J Med Chem52, 4860-4868. PubMed  Europe PubMed DOI  I
  225. Ekonomiuk,D., Su,X.C., Ozawa,K., Bodenreider,C., Lim,S.P., Yin,Z., Keller,T.H., Beer,D., Patel,V., Otting,G., Caflisch,A. and Huang,D.
    Discovery of a non-peptidic inhibitor of West Nile virus NS3 protease by high-throughput docking
    PLoS Negl Trop Dis3, e356-e356. PubMed  Europe PubMed DOI  I
  226. Ezgimen,M.D., Mueller,N.H., Teramoto,T. and Padmanabhan,R.
    Effects of detergents on the West Nile virus protease activity
    Bioorg Med Chem17, 3278-3282. PubMed  Europe PubMed DOI
  227. Robin,G., Chappell,K., Stoermer,M.J., Hu,S.H., Young,P.R., Fairlie,D.P. and Martin,J.L.
    Structure of West Nile virus NS3 protease: ligand stabilization of the catalytic conformation
    J Mol Biol385, 1568-1577. PubMed  Europe PubMed DOI  S  T
  228. Steuer,C., Heinonen,K.H., Kattner,L. and Klein,C.D.
    Optimization of assay conditions for dengue virus protease: effect of various polyols and nonionic detergents
    J Biomol Screen14, 1102-1108. PubMed  Europe PubMed DOI  A
  229. Su,X.C., Ozawa,K., Qi,R., Vasudevan,S.G., Lim,S.P. and Otting,G.
    NMR analysis of the dynamic exchange of the NS2B cofactor between open and closed conformations of the West Nile virus NS2B-NS3 protease
    PLoS Negl Trop Dis3, e561-e561. PubMed  Europe PubMed DOI
  230. Su,X.C., Ozawa,K., Yagi,H., Lim,S.P., Wen,D., Ekonomiuk,D., Huang,D., Keller,T.H., Sonntag,S., Caflisch,A., Vasudevan,S.G. and Otting,G.
    NMR study of complexes between low molecular mass inhibitors and the West Nile virus NS2B-NS3 protease
    FEBS J276, 4244-4255. PubMed  Europe PubMed DOI  S  I
  231. Tomlinson,S.M., Malmstrom,R.D., Russo,A., Mueller,N., Pang,Y.P. and Watowich,S.J.
    Structure-based discovery of dengue virus protease inhibitors
    Antiviral Res82, 110-114. PubMed  Europe PubMed DOI  I
  232. Tomlinson,S.M., Malmstrom,R.D. and Watowich,S.J.
    New approaches to structure-based discovery of dengue protease inhibitors
    Infect Disord Drug Targets9, 327-343. PubMed  Europe PubMed  I
  233. Yang,T.C., Shiu,S.L., Chuang,P.H., Lin,Y.J., Wan,L., Lan,Y.C. and Lin,C.W.
    Japanese encephalitis virus NS2B-NS3 protease induces caspase 3 activation and mitochondria-mediated apoptosis in human medulloblastoma cells
    Virus Res143, 77-85. PubMed  Europe PubMed DOI
  234. Zuo,Z., Liew,O.W., Chen,G., Chong,P.C., Lee,S.H., Chen,K., Jiang,H., Puah,C.M. and Zhu,W.
    Mechanism of NS2B-mediated activation of NS3pro in Dengue virus: molecular dynamics simulations and bioassays
    J Virol83, 1060-1070. PubMed  Europe PubMed DOI  A
    235. 2008
  235. Chappell,K.J., Stoermer,M.J., Fairlie,D.P. and Young,P.R.
    West Nile virus NS2B/NS3 protease as an antiviral target
    Curr Med Chem15, 2771-2784. PubMed  Europe PubMed DOI
  236. Chappell,K.J., Stoermer,M.J., Fairlie,D.P. and Young,P.R.
    Mutagenesis of the West Nile virus NS2B cofactor domain reveals two regions essential for protease activity
    J Gen Virol89, 1010-1014. PubMed  Europe PubMed DOI
  237. Chernov,A.V., Shiryaev,S.A., Aleshin,A.E., Ratnikov,B.I., Smith,J.W., Liddington,R.C. and Strongin,A.Y.
    The two-component NS2B-NS3 proteinase represses DNA unwinding activity of the West Nile virus NS3 helicase
    J Biol Chem283, 17270-17278. PubMed  Europe PubMed DOI  T
  238. Iempridee,T., Thongphung,R., Angsuthanasombat,C. and Katzenmeier,G.
    A comparative biochemical analysis of the NS2B(H)-NS3pro protease complex from four dengue virus serotypes
    Biochim Biophys Acta1780, 989-994. PubMed  Europe PubMed DOI
  239. Luo,D., Xu,T., Hunke,C., Gruber,G., Vasudevan,S.G. and Lescar,J.
    Crystal structure of the NS3 protease-helicase from Dengue virus
    J Virol82, 173-183. PubMed  Europe PubMed DOI  S
  240. Marcon,L., Kozak,D., Battersby,B.J., Chappell,K.J., Fairlie,D.P., Young,P. and Trau,M.
    A dual-purpose synthetic colloidal platform for protease mapping: substrate profiling for Dengue and West Nile virus proteases
    Anal Biochem376, 151-153. PubMed  Europe PubMed DOI  P
  241. Mueller,N.H., Pattabiraman,N., Ansarah-Sobrinho,C., Viswanathan,P., Pierson,T.C. and Padmanabhan,R.
    Identification and biochemical characterization of small-molecule inhibitors of West Nile virus serine protease by a high-throughput screen
    Antimicrobial Agents Chemother52, 3385-3393. PubMed  Europe PubMed DOI  I
  242. Othman,R., Kiat,T.S., Khalid,N., Yusof,R., Newhouse,E.I., Newhouse,J.S., Alam,M. and Rahman,N.A.
    Docking of noncompetitive inhibitors into Dengue virus type 2 protease: understanding the interactions with allosteric binding sites
    J Chem Inf Model48, 1582-1591. PubMed  Europe PubMed DOI  I
  243. Pastorino,B., Rolland,D., Peyrefitte,C.N., Wurtz,N., Almeras,L., Bessaud,M. and Tolou,H.J.
    Improvement of the purification of Saint Louis encephalitis virus NS2B-NS3 recombinant protease expressed in Escherichia coli
    J Chromatogr B Analyt Technol Biomed Life Sci868, 58-63. PubMed  Europe PubMed DOI  E
  244. Prusis,P., Lapins,M., Yahorava,S., Petrovska,R., Niyomrattanakit,P., Katzenmeier,G. and Wikberg,J.E.
    Proteochemometrics analysis of substrate interactions with dengue virus NS3 proteases
    Bioorg Med Chem16, 9369-9377. PubMed  Europe PubMed DOI  T
  245. Radichev,I., Shiryaev,S.A., Aleshin,A.E., Ratnikov,B.I., Smith,J.W., Liddington,R.C. and Strongin,A.Y.
    Structure-based mutagenesis identifies important novel determinants of the NS2B cofactor of the West Nile virus two-component NS2B-NS3 proteinase
    J Gen Virol89, 636-641. PubMed  Europe PubMed DOI
  246. Schrauf,S., Schlick,P., Skern,T. and Mandl,C.W.
    Functional analysis of potential carboxy-terminal cleavage sites of tick-borne encephalitis virus capsid protein
    J Virol82, 2218-2229. PubMed  Europe PubMed DOI  P
  247. Stoermer,M.J., Chappell,K.J., Liebscher,S., Jensen,C.M., Gan,C.H., Gupta,P.K., Xu,W.J., Young,P.R. and Fairlie,D.P.
    Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity
    J Med Chem51, 5714-5721. PubMed  Europe PubMed DOI  I
  248. Tomlinson,S.M. and Watowich,S.J.
    Substrate inhibition kinetic model for West Nile virus NS2B-NS3 protease
    Biochemistry47, 11763-11770. PubMed  Europe PubMed DOI  I
  249. Yamashita,T., Unno,H., Mori,Y., Tani,H., Moriishi,K., Takamizawa,A., Agoh,M., Tsukihara,T. and Matsuura,Y.
    Crystal structure of the catalytic domain of Japanese encephalitis virus NS3 helicase/nucleoside triphosphatase at a resolution of 1.8 A
    Virology373, 426-436. PubMed  Europe PubMed DOI  S
    250. 2007
  250. Aleshin,A.E., Shiryaev,S.A., Strongin,A.Y. and Liddington,R.C.
    Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold
    Protein Sci16, 795-806. PubMed  Europe PubMed DOI  P  S
  251. Alves,F.M., Hirata,I.Y., Gouvea,I.E., Alves,M.F., Meldal,M., Bromme,D., Juliano,L. and Juliano,M.A.
    Controlled peptide solvation in portion-mixing libraries of FRET peptides: improved specificity determination for dengue 2 virus NS2B-NS3 protease and human cathepsin S
    J Comb Chem9, 627-634. PubMed  Europe PubMed DOI
  252. Bera,A.K., Kuhn,R.J. and Smith,J.L.
    Functional characterization of cis and trans activity of the flavivirus NS2B-NS3 protease
    J Biol Chem282, 12883-12892. PubMed  Europe PubMed DOI  P
  253. Chappell,K.J., Stoermer,M.J., Fairlie,D.P. and Young,P.R.
    Generation and characterization of proteolytically active and highly stable truncated and full-length recombinant West Nile virus NS3
    Protein Expr Purif53, 87-96. PubMed  Europe PubMed DOI  E
  254. Gouvea,I.E., Izidoro,M.A., Judice,W.A., Cezari,M.H., Caliendo,G., Santagada,V., dos Santos,C.N., Queiroz,M.H., Juliano,M.A., Young,P.R., Fairlie,D.P. and Juliano,L.
    Substrate specificity of recombinant dengue 2 virus NS2B-NS3 protease: influence of natural and unnatural basic amino acids on hydrolysis of synthetic fluorescent substrates
    Arch Biochem Biophys457, 187-196. PubMed  Europe PubMed DOI  P
  255. Johnston,P.A., Phillips,J., Shun,T.Y., Shinde,S., Lazo,J.S., Huryn,D.M., Myers,M.C., Ratnikov,B.I., Smith,J.W., Su,Y., Dahl,R., Cosford,N.D., Shiryaev,S.A. and Strongin,A.Y.
    HTS identifies novel and specific uncompetitive inhibitors of the two-component NS2B-NS3 proteinase of West Nile virus
    Assay Drug Dev Technol5, 737-750. PubMed  Europe PubMed DOI  P  T
  256. Lin,C.W., Huang,H.D., Shiu,S.Y., Chen,W.J., Tsai,M.H., Huang,S.H., Wan,L. and Lin,Y.J.
    Functional determinants of NS2B for activation of Japanese encephalitis virus NS3 protease
    Virus Res127, 88-94. PubMed  Europe PubMed DOI
  257. Lohr,K., Knox,J.E., Phong,W.Y., Ma,N.L., Yin,Z., Sampath,A., Patel,S.J., Wang,W.L., Chan,W.L., Rao,K.R., Wang,G., Vasudevan,S.G., Keller,T.H. and Lim,S.P.
    Yellow fever virus NS3 protease: peptide-inhibition studies
    J Gen Virol88, 2223-2227. PubMed  Europe PubMed DOI  I
  258. Melino,S. and Paci,M.
    Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach
    FEBS J274, 2986-3002. PubMed  Europe PubMed DOI
  259. Mueller,N.H., Yon,C., Ganesh,V.K. and Padmanabhan,R.
    Characterization of the West Nile virus protease substrate specificity and inhibitors
    Int J Biochem Cell Biol39, 606-614. PubMed  Europe PubMed DOI  E  P
  260. Othman,R., Wahab,H.A., Yusof,R. and Rahman,N.A.
    Analysis of secondary structure predictions of Dengue virus type 2 NS2B/NS3 against crystal structure to evaluate the predictive power of the in silico methods
    In Silico Biol7, 215-224. PubMed  Europe PubMed  S
  261. Pastorino,B.A., Peyrefitte,C.N., Grandadam,M., Lebrun,R., Moinier,D., Rolland,D., Tolou,H.J. and Bessaud,M.
    Unexpected altered specificity is responsible for St. Louis encephalitis virus recombinant protease autoproteolysis
    Protein Pept Lett14, 79-82. PubMed  Europe PubMed DOI  P
  262. Peyrefitte,C.N., Pastorino,B.A., Grandadam,M., Rolland,D., Tolou,H.J. and Bessaud,M.
    Enzymatic characterization of a trypsin-like serine protease encoded by the genome of Cell fusing agent virus
    Virus Genes34, 185-191. PubMed  Europe PubMed DOI
  263. Shiryaev,S.A., Kozlov,I.A., Ratnikov,B.I., Smith,J.W., Lebl,M. and Strongin,A.Y.
    Cleavage preference distinguishes the two-component NS2B-NS3 serine proteinases of Dengue and West Nile viruses
    Biochem J401, 743-752. PubMed  Europe PubMed DOI  P
  264. Shiryaev,S.A., Ratnikov,B.I., Aleshin,A.E., Kozlov,I.A., Nelson,N.A., Lebl,M., Smith,J.W., Liddington,R.C. and Strongin,A.Y.
    Switching the substrate specificity of the two-component NS2B-NS3 flavivirus proteinase by structure-based mutagenesis
    J Virol81, 4501-4509. PubMed  Europe PubMed DOI  P  T
  265. Shiryaev,S.A., Aleshin,A.E., Ratnikov,B.I., Smith,J.W., Liddington,R.C. and Strongin,A.Y.
    Expression and purification of a two-component flaviviral proteinase resistant to autocleavage at the NS2B-NS3 junction region
    Protein Expr Purif52, 334-339. PubMed  Europe PubMed DOI  E
    266. 2006
  266. [YEAR:24-2-2006]Bessaud,M., Pastorino,B.A., Peyrefitte,C.N., Rolland,D., Grandadam,M. and Tolou,H.J.
    Functional characterization of the NS2B/NS3 protease complex from seven viruses belonging to different groups inside the genus Flavivirus
    Virus Res120, 79-90. PubMed  Europe PubMed DOI
  267. Chappell,K.J., Stoermer,M.J., Fairlie,D.P. and Young,P.R.
    Insights to substrate binding and processing by West Nile Virus NS3 protease through combined modeling, protease mutagenesis, and kinetic studies
    J Biol Chem281, 38448-38458. PubMed  Europe PubMed DOI  P
  268. [YEAR:1-2-2006]D'arcy,A., Chaillet,M., Schiering,N., Villard,F., Lim,S.P., Lefeuvre,P. and Erbel,P.
    Purification and crystallization of dengue and West Nile virus NS2B-NS3 complexes
    Acta Crystallograph Sect F Struct Biol Cryst Commun62, 157-162. PubMed  Europe PubMed DOI
  269. [YEAR:12-3-2006]Erbel,P., Schiering,N., D'arcy,A., Renatus,M., Kroemer,M., Lim,S.P., Yin,Z., Keller,T.H., Vasudevan,S.G. and Hommel,U.
    Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus
    Nat Struct Mol Biol13, 372-373. PubMed  Europe PubMed DOI  S
  270. [YEAR:2-11-2006]Knox,J.E., Ma,N.L., Yin,Z., Patel,S.J., Wang,W.L., Chan,W.L., Ranga Rao,K.R., Wang,G., Ngew,X., Patel,V., Beer,D., Lim,S.P., Vasudevan,S.G. and Keller,T.H.
    Peptide inhibitors of West Nile NS3 protease: SAR study of tetrapeptide aldehyde inhibitors
    J Med Chem49, 6585-6590. PubMed  Europe PubMed DOI  I
  271. Lee,Y.K., Rozana,O., Habibah,A.W., Yusof,R. and Noorsaadah,A.R.
    A revisit into the DEN2 NS2B/NS3 virus protease homology model: structural verification and comparison with crystal structure of HCV NS3/4A and DEN2 NS3
    Malays J Sci25, 15-22.
  272. [YEAR:9-11-2006]Lin,C.W., Lin,K.H., Lyu,P.C. and Chen,W.J.
    Japanese encephalitis virus NS2B-NS3 protease binding to phage-displayed human brain proteins with the domain of trypsin inhibitor and basic region leucine zipper
    Virus Res116, 106-113. PubMed  Europe PubMed DOI
  273. Melino,S., Fucito,S., Campagna,A., Wrubl,F., Gamarnik,A., Cicero,D.O. and Paci,M.
    The active essential CFNS3d protein complex
    FEBS J273, 3650-3662. PubMed  Europe PubMed DOI
  274. [YEAR:21-2-2006]Niyomrattanakit,P., Yahorava,S., Mutule,I., Mutulis,F., Petrovska,R., Prusis,P., Katzenmeier,G. and Wikberg,J.E.
    Probing the substrate specificity of the Dengue virus type 2 NS3 serine protease by using internally quenched fluorescent peptides
    Biochem J397, 203-211. PubMed  Europe PubMed DOI  P
  275. Pastorino,B.A., Peyrefitte,C.N., Grandadam,M., Thill,M.C., Tolou,H.J. and Bessaud,M.
    Mutagenesis analysis of the NS2B determinants of the Alkhurma virus NS2B-NS3 protease activation
    J Gen Virol87, 3279-3283. PubMed  Europe PubMed DOI
  276. [YEAR:19-10-2006]Ramanathan,M.P., Chambers,J.A., Pankhong,P., Chattergoon,M., Attatippaholkun,W., Dang,K., Shah,N. and Weiner,D.B.
    Host cell killing by the West Nile Virus NS2B-NS3 proteolytic complex: NS3 alone is sufficient to recruit caspase-8-based apoptotic pathway
    Virology345, 56-72. PubMed  Europe PubMed DOI
  277. [YEAR:15-1-2006]Seidah,N.G.
    Unexpected similarity between the cytosolic West Nile virus NS3 and the secretory furin-like serine proteinases
    Biochem J393, e1-e3. PubMed  Europe PubMed DOI  P
  278. [YEAR:15-1-2006]Shiryaev,S.A., Ratnikov,B.I., Chekanov,A.V., Sikora,S., Rozanov,D.V., Godzik,A., Wang,J., Smith,J.W., Huang,Z., Lindberg,I., Samuel,M.A., Diamond,M.S. and Strongin,A.Y.
    Cleavage targets and the D-arginine-based inhibitors of the West Nile virus NS3 processing proteinase
    Biochem J393, 503-511. PubMed  Europe PubMed DOI  P  I
  279. [YEAR:20-10-2006]Yin,Z., Patel,S.J., Wang,W.L., Chan,W.L., Ranga Rao,K.R., Wang,G., Ngew,X., Patel,V., Beer,D., Knox,J.E., Ma,N.L., Ehrhardt,C., Lim,S.P., Vasudevan,S.G. and Keller,T.H.
    Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors
    Bioorg Med Chem Lett16, 40-43. PubMed  Europe PubMed DOI  I
  280. [YEAR:20-10-2006]Yin,Z., Patel,S.J., Wang,W.L., Wang,G., Chan,W.L., Rao,K.R., Alam,J., Jeyaraj,D.A., Ngew,X., Patel,V., Beer,D., Lim,S.P., Vasudevan,S.G. and Keller,T.H.
    Peptide inhibitors of dengue virus NS3 protease. Part 1: Warhead
    Bioorg Med Chem Lett16, 36-39. PubMed  Europe PubMed DOI  I
  281. [YEAR:13-9-2006]Zhou,H., Singh,N.J. and Kim,K.S.
    Homology modeling and molecular dynamics study of West Nile virus NS3 protease: A molecular basis for the catalytic activity increased by the NS2B cofactor
    Proteins65, 692-701. PubMed  Europe PubMed DOI
    282. 2005
  282. Bessaud,M., Grard,G., Peyrefitte,C.N., Pastorino,B., Rolland,D., Charrel,R.N., de Lamballerie,X. and Tolou,H.J.
    Identification and enzymatic characterization of NS2B-NS3 protease of Alkhurma virus, a class-4 flavivirus
    Virus Res107, 57-62. PubMed  Europe PubMed DOI
  283. [YEAR:20-5-2005]Chanprapaph,S., Saparpakorn,P., Sangma,C., Niyomrattanakit,P., Hannongbua,S., Angsuthanasombat,C. and Katzenmeier,G.
    Competitive inhibition of the dengue virus NS3 serine protease by synthetic peptides representing polyprotein cleavage sites
    Biochem Biophys Res Commun330, 1237-1246. PubMed  Europe PubMed DOI  P
  284. [YEAR:19-11-2005]Chappell,K.J., Nall,T.A., Stoermer,M.J., Fang,N.X., Tyndall,J.D., Fairlie,D.P. and Young,P.R.
    Site-directed mutagenesis and kinetic studies of the West Nile Virus NS3 protease identify key enzyme-substrate interactions
    J Biol Chem280, 2896-2903. PubMed  Europe PubMed DOI
  285. [YEAR:3-1-2005]Ganesh,V.K., Muller,N., Judge,K., Luan,C.H., Padmanabhan,R. and Murthy,K.H.
    Identification and characterization of nonsubstrate based inhibitors of the essential dengue and West Nile virus proteases
    Bioorg Med Chem13, 257-264. PubMed  Europe PubMed DOI  I
  286. [YEAR:1-6-2005]Li,J., Lim,S.P., Beer,D., Patel,V., Wen,D., Tumanut,C., Tully,D.C., Williams,J.A., Jiricek,J., Priestle,J.P., Harris,J.L. and Vasudevan,S.G.
    Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries
    J Biol Chem280, 28766-28774. PubMed  Europe PubMed DOI  P
  287. [YEAR:21-1-2005]Muri,E.M., Gomes,M., Jr., Albuquerque,M.G., da Cunha,E.F., de Alencastro,R.B., Williamson,J.S. and Antunes,O.A.
    Pseudo-peptides derived from isomannide as potential inhibitors of serine proteases
    Amino Acids28, 413-419. PubMed  Europe PubMed DOI  I
  288. Xu,T., Sampath,A., Chao,A., Wen,D., Nanao,M., Chene,P., Vasudevan,S.G. and Lescar,J.
    Structure of the Dengue virus helicase/nucleoside triphosphatase catalytic domain at a resolution of 2.4 A
    J Virol79, 10278-10288. PubMed  Europe PubMed DOI  S
    289. 2004
  289. Kummerer,B.M., Amberg,S.M. and Rice,C.M.
    Flavivirin
    [ISSN:0-12-079610-4]2, 1769-1773.  V
  290. [YEAR:18-8-2004]Nall,T.A., Chappell,K.J., Stoermer,M.J., Fang,N.X., Tyndall,J.D., Young,P.R. and Fairlie,D.P.
    Enzymatic characterization and homology model of a catalytically active recombinant West Nile virus NS3 protease
    J Biol Chem279, 48535-48542. PubMed  Europe PubMed DOI
  291. Niyomrattanakit,P., Winoyanuwattikun,P., Chanprapaph,S., Angsuthanasombat,C., Panyim,S. and Katzenmeier,G.
    Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation
    J Virol78, 13708-13716. PubMed  Europe PubMed DOI  S
    292. 2003
  292. Shafee,N. and AbuBakar,S.
    Dengue virus type 2 NS3 protease and NS2B-NS3 protease precursor induce apoptosis
    J Gen Virol84, 2191-2195. PubMed  Europe PubMed DOI
  293. Wu,C.F., Wang,S.H., Sun,C.M., Hu,S.T. and Syu,W.J.
    Activation of dengue protease autocleavage at the NS2B-NS3 junction by recombinant NS3 and GST-NS2B fusion proteins
    J Virol Methods114, 45-54. PubMed  Europe PubMed DOI
    294. 2002
  294. Arakaki,T.L., Fang,N.X., Fairlie,D.P., Young,P.R. and Martin,J.L.
    Catalytically active Dengue virus NS3 protease forms aggregates that are separable by size exclusion chromatography
    Protein Expr Purif25, 241-247. PubMed  Europe PubMed DOI
  295. Prikhod'ko,G.G., Prikhod'ko,E.A., Pletnev,A.G. and Cohen,J.I.
    Langat flavivirus protease NS3 binds caspase-8 and induces apoptosis
    J Virol76, 5701-5710. PubMed  Europe PubMed DOI  I
  296. Scaramozzino,N., Crance,J.M., Drouet,C., Roebuck,J.P., Drouet,E., Jouan,A. and Garin,D.
    NS3 protease of Langat tick-borne flavivirus cleaves serine protease substrates
    Biochem Biophys Res Commun294, 16-22. PubMed  Europe PubMed DOI
    297. 2001
  297. [YEAR:7-12-2001]Leung,D., Schroder,K., White,H., Fang,N.X., Stoermer,M.J., Abbenante,G., Martin,J.L., Young,P.R. and Fairlie,D.P.
    Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors
    J Biol Chem276, 45762-45771. PubMed  Europe PubMed DOI
  298. Matusan,A.E., Kelley,P.G., Pryor,M.J., Whisstock,J.C., Davidson,A.D. and Wright,P.J.
    Mutagenesis of the dengue virus type 2 NS3 proteinase and the production of growth-restricted virus
    J Gen Virol82, 1647-1656. PubMed  Europe PubMed
    299. 2000
  299. [YEAR:30-9-2000]Droll,D.A., Krishna Murthy,H.M. and Chambers,T.J.
    Yellow fever virus NS2B-NS3 protease: charged-to-alanine mutagenesis and deletion analysis define regions important for protease complex formation and function
    Virology275, 335-347. PubMed  Europe PubMed DOI
  300. [YEAR:7-4-2000]Yusof,R., Clum,S., Wetzel,M., Murthy,H.M. and Padmanabhan,R.
    Purified NS2B/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro
    J Biol Chem275, 9963-9969. PubMed  Europe PubMed DOI
    301. 1999
  301. Amberg,S.M. and Rice,C.M.
    Mutagenesis of the NS2B-NS3-mediated cleavage site in the flavivirus capsid protein demonstrates a requirement for coordinated processing
    J Virol73, 8083-8094. PubMed  Europe PubMed
  302. Brinkworth,R.I., Fairlie,D.P., Leung,D. and Young,P.R.
    Homology model of the dengue 2 virus NS3 protease: putative interactions with both substrate and NS2B cofactor
    J Gen Virol80, 1167-1177. PubMed  Europe PubMed  S
  303. Krishna Murthy,H.M., Judge,K., DeLucas,L., Clum,S. and Padmanabhan,R.
    Crystallization, characterization and measurement of MAD data on crystals of dengue virus NS3 serine protease complexed with mung-bean Bowman-Birk inhibitor
    Acta Crystallogr D Biol Crystallogr55, 1370-1372. PubMed  Europe PubMed DOI
    304. 1998
  304. Ryan,M.D., Monaghan,S. and Flint,M.
    Virus-encoded proteinases of the Flaviviridae
    J Gen Virol79, 947-959. PubMed  Europe PubMed
  305. Valle,R.P. and Falgout,B.
    Mutagenesis of the NS3 protease of dengue virus type 2
    J Virol72, 624-632. PubMed  Europe PubMed
    306. 1997
  306. [YEAR:5-12-1997]Clum,S., Ebner,K.E. and Padmanabhan,R.
    Cotranslational membrane insertion of the serine proteinase precursor NS2B-NS3(Pro) of dengue virus type 2 is required for efficient in vitro processing and is mediated through the hydrophobic regions of NS2B
    J Biol Chem272, 30715-30723. PubMed  Europe PubMed DOI
  307. Teo,K.F. and Wright,P.J.
    Internal proteolysis of the NS3 protein specified by dengue virus 2
    J Gen Virol78, 337-341. PubMed  Europe PubMed
    308. 1996
  308. Rice,C.M.
    Flaviridae: the viruses and their replication
    3, 931-959.
    309. 1995
  309. Chambers,T.J., Nestorowicz,A. and Rice,C.M.
    Mutagenesis of the yellow fever virus NS2B/3 cleavage site: determinants of cleavage site specificity and effects on polyprotein processing and viral replication
    J Virol69, 1600-1605. PubMed  Europe PubMed  P
  310. Falgout,B. and Markoff,L.
    Evidence that flavivirus NS1-NS2A cleavage is mediated by a membrane-bound host protease in the endoplasmic reticulum
    J Virol69, 7232-7243. PubMed  Europe PubMed
  311. Jan,L.R., Yang,C.S., Trent,D.W., Falgout,B. and Lai,C.J.
    Processing of Japanese encephalitis virus non-structural proteins: NS2B-NS3 complex and heterologous proteases
    J Gen Virol76, 573-580. PubMed  Europe PubMed
  312. Yamshchikov,V.F. and Compans,R.W.
    Formation of the flavivirus envelope: Role of the viral NS2B-NS3 protease
    J Virol69, 1995-2003. PubMed  Europe PubMed
    313. 1994
  313. Amberg,S.M., Nestorowicz,A., McCourt,D.W. and Rice,C.M.
    NS2b-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies
    J Virol68, 3794-3802. PubMed  Europe PubMed
  314. [YEAR:15-2-1994]Nestorowicz,A., Chambers,T.J. and Rice,C.M.
    Mutagenesis of the yellow fever virus NS2A/2B cleavage site: effects on proteolytic processing, viral replication, and evidence for alternative processing of the NS2A protein
    Virology199, 114-123. PubMed  Europe PubMed DOI
  315. Yamshchikov,V.F. and Compans,R.W.
    Processing of the intracellular form of the west Nile virus capsid protein by the viral NS2b-NS3 protease: an in vitro study
    J Virol68, 5765-5771. PubMed  Europe PubMed
    316. 1993
  316. Arias,C.F., Preugschat,F. and Strauss,J.H.
    Dengue 2 virus NS2B and NS3 form a stable complex that can cleave NS3 within the helicase domain
    Virology193, 888-899. PubMed  Europe PubMed DOI
  317. Falgout,B., Miller,R.H. and Lai,C.J.
    Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity
    J Virol67, 2034-2042. PubMed  Europe PubMed
  318. Lin,C., Amberg,S.M., Chambers,T.J. and Rice,C.M.
    Cleavage at a novel site in the NS4A region by the yellow fever virus NS2B-3 proteinase is a prerequisite for processing at the downstream 4A/4B signalase site
    J Virol67, 2327-2335. PubMed  Europe PubMed
  319. Lin,C., Chambers,T.J. and Rice,C.M.
    Mutagenesis of conserved residues at the yellow fever virus 3/4A and 4B/5 dibasic cleavage sites: Effects on cleavage efficiency and polyprotein processing
    Virology192, 596-604. PubMed  Europe PubMed DOI
  320. [YEAR:1-7-1993]Lobigs,M.
    Flavivirus premembrane protein cleavage and spike heterodimer secretion require the function of the viral proteinase NS3
    Proc Natl Acad Sci U S A90, 6218-6222. PubMed  Europe PubMed
    321. 1992
  321. Cahour,A., Falgout,B. and Lai,C.J.
    Cleavage of the dengue virus polyprotein at the NS3/NS4A and NS4B/NS5 junctions is mediated by viral protease NS2B-NS3, whereas NS4A/NS4B may be processed by a cellular protease
    J Virol66, 1535-1542. PubMed  Europe PubMed
  322. Lobigs,M.
    Proteolytic processing of a Murray Valley encephalitis virus non-structural polyprotein segment containing the viral proteinase: accumulation of a NS3-4A precursor which requires mature NS3 for efficient processing
    J Gen Virol73, 2305-2312. PubMed  Europe PubMed
  323. Zhang,L., Mohan,P.M. and Padmanabhan,R.
    Processing and localization of Dengue virus type 2 polyprotein precursor NS3-NS4A-NS4B-NS5
    J Virol66, 7549-7554. PubMed  Europe PubMed
    324. 1991
  324. Chambers,T.J., Grakoui,A. and Rice,C.M.
    Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites
    J Virol65, 6042-6050. PubMed  Europe PubMed  P
  325. Falgout,B., Pethel,M., Zhang,Y.M. and Lai,C.J.
    Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins
    J Virol65, 2467-2475. PubMed  Europe PubMed
  326. Preugschat,F., Lenches,E.M. and Strauss,J.H.
    Flavivirus enzyme-substrate interactions studied with chimeric proteinases: Identification of an intragenic locus important for substrate recognition
    J Virol65, 4749-4758. PubMed  Europe PubMed
  327. Wengler,G., Czaya,G., Farber,P.M. and Hegemann,J.H.
    In vitro synthesis of West Nile virus proteins indicates that the amino-terminal segment of the NS3 protein contains the active centre of the protease which cleaves the viral polyprotein after multiple basic amino acids
    J Gen Virol72, 851-858. PubMed  Europe PubMed
    328. 1990
  328. Chambers,T.J., Weir,R.C., Grakoui,A., McCourt,D.W., Bazan,J.F., Fletterick,R.J. and Rice,C.M.
    Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site- specific cleavages in the viral polyprotein
    Proc Natl Acad Sci U S A87, 8898-8902. PubMed  Europe PubMed DOI
  329. Chambers,T.J., McCourt,D.W. and Rice,C.M.
    Production of yellow fever virus proteins in infected cells: identification of discrete polyprotein species and analysis of cleavage kinetics using region-specific polyclonal antisera
    Virology177, 159-174. PubMed  Europe PubMed DOI
  330. Preugschat,F., Yao,C.W. and Strauss,J.H.
    In vitro processing of dengue virus type 2 nonstructural proteins NS2A, NS2B, and NS3
    J Virol64, 4364-4374. PubMed  Europe PubMed
    331. 1989
  331. Bazan,J.F. and Fletterick,R.J.
    Detection of a trypsin-like serine protease domain in flaviviruses and pestiviruses
    Virology171, 637-639. PubMed  Europe PubMed DOI
  332. Nowak,T., Farber,P.M., Wengler,G. and Wengler,G.
    Analyses of the terminal sequences of West Nile virus structural proteins and of the in vitro translation of these proteins allow the proposal of a complete scheme of the proteolytic cleavages involved in their synthesis
    Virology169, 365-376. PubMed  Europe PubMed
  333. Speight,G. and Westaway,E.G.
    Carboxy-terminal analysis of nine proteins specified by the flavivirus Kunjin: evidence that only the intracellular core protein is truncated
    J Gen Virol70, 2209-2214. PubMed  Europe PubMed
    334. 1985
  334. Rice,C.M., Lenches,E.M., Eddy,S.R., Shin,S.J., Sheets,R.L. and Strauss,J.H.
    Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution
    Science229, 726-733. PubMed  Europe PubMed

feedback
Page created 8-September-2023

EMBL-EBI logo

© 2025 EBI
Terms of use